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A B S T R A C T
Background
Problem alcohol use is common among people who use illicit drugs (PWID) and is associated with adverse health outcomes. It is also
an important factor contributing to a poor prognosis among drug users with hepatitis C virus (HCV) as it impacts on progression to
hepatic cirrhosis or opioid overdose in PWID.
Objectives
To assess the effectiveness of psychosocial interventions to reduce alcohol consumption in PWID (users of opioids and stimulants).
Search methods
We searched the Cochrane Drugs and Alcohol Group trials register, the Cochrane Central Register of Controlled Trials (CENTRAL),
MEDLINE, Embase, CINAHL, and PsycINFO, from inception up to August 2017, and the reference lists of eligible articles. We also
searched: 1) conference proceedings (online archives only) of the Society for the Study of Addiction, International Harm Reduction
Association, International Conference onAlcoholHarmReduction andAmericanAssociation for the Treatment ofOpioidDependence;
and 2) online registers of clinical trials: Current Controlled Trials, ClinicalTrials.gov, CenterWatch and theWorld Health Organization
International Clinical Trials Registry Platform.
Selection criteria
We included randomised controlled trials comparing psychosocial interventions with other psychosocial treatment, or treatment as
usual, in adult PWIDs (aged at least 18 years) with concurrent problem alcohol use.
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Data collection and analysis
We used the standard methodological procedures expected by Cochrane.
Main results
We included seven trials (825 participants). We judged the majority of the trials to have a high or unclear risk of bias.
The psychosocial interventions considered in the studies were: cognitive-behavioural coping skills training (one study), twelve-step
programme (one study), brief intervention (three studies), motivational interviewing (two studies), and brief motivational interviewing
(one study). Two studies were considered in two comparisons. There were no data for the secondary outcome, alcohol-related harm.
The results were as follows.
Comparison 1: cognitive-behavioural coping skills training versus twelve-step programme (one study, 41 participants)
There was no significant difference between groups for either of the primary outcomes (alcohol abstinence assessed with Substance
Abuse Calendar and breathalyser at one year: risk ratio (RR) 2.38 (95% confidence interval [CI] 0.10 to 55.06); and retention in
treatment, measured at end of treatment: RR 0.89 (95% CI 0.62 to 1.29), or for any of the secondary outcomes reported. The quality
of evidence for the primary outcomes was very low.
Comparison 2: brief intervention versus treatment as usual (three studies, 197 participants)
There was no significant difference between groups for either of the primary outcomes (alcohol use, measured as scores on the Alcohol
Use Disorders Identification Test (AUDIT) or Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) at three months:
standardised mean difference (SMD) 0.07 (95% CI -0.24 to 0.37); and retention in treatment, measured at three months: RR 0.94
(95% CI 0.78 to 1.13), or for any of the secondary outcomes reported. The quality of evidence for the primary outcomes was low.
Comparison 3: motivational interviewing versus treatment as usual or educational intervention only (three studies, 462 par-
ticipants)
There was no significant difference between groups for either of the primary outcomes (alcohol use, measured as scores on the AUDIT
or ASSIST at three months: SMD 0.04 (95% CI -0.29 to 0.37); and retention in treatment, measured at three months: RR 0.93 (95%
CI 0.60 to 1.43), or for any of the secondary outcomes reported. The quality of evidence for the primary outcomes was low.
Comparison 4: brief motivational intervention (BMI) versus assessment only (one study, 187 participants)
More people reduced alcohol use (by seven or more days in the past month, measured at six months) in the BMI group than in the
control group (RR 1.67; 95% CI 1.08 to 2.60). There was no difference between groups for the other primary outcome, retention in
treatment, measured at end of treatment: RR 0.98 (95% CI 0.94 to 1.02), or for any of the secondary outcomes reported. The quality
of evidence for the primary outcomes was moderate.
Comparison 5: motivational interviewing (intensive) versus motivational interviewing (one study, 163 participants)
There was no significant difference between groups for either of the primary outcomes (alcohol use, measured using the Addiction
Severity Index-alcohol score (ASI) at two months: MD 0.03 (95% CI 0.02 to 0.08); and retention in treatment, measured at end of
treatment: RR 17.63 (95% CI 1.03 to 300.48), or for any of the secondary outcomes reported. The quality of evidence for the primary
outcomes was low.
Authors’ conclusions
We found low to very low-quality evidence to suggest that there is no difference in effectiveness between different types of psychosocial
interventions to reduce alcohol consumption among people who use illicit drugs, and that brief interventions are not superior to
assessment-only or to treatment as usual. No firm conclusions can be made because of the paucity of the data and the low quality of
the retrieved studies.
P L A I N L A N G U A G E S U M M A R Y
Which talking therapies work for people who use drugs and also have alcohol problems?
Review question
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We wanted to see whether talking therapies reduce drinking in adult users of illicit drugs (mainly opioids and stimulants). We also
wanted to find out whether one type of therapy is more effective than another.
Background
Drinking alcohol above the low-risk drinking limits can lead to serious alcohol use problems or disorders. Drinking above those limits
is common in people who also have problems with other drugs. It worsens their physical and mental health. Talking therapies aim to
identify an alcohol problem and motivate an individual to do something about it. Talking therapies can be given by trained doctors,
nurses, counsellors, psychologists, etc. Talking therapies may help reduce alcohol use but we wanted to find out if they can help people
who also have problems with other drugs.
Search date: the evidence is current to August 2017.
Study characteristics
We found seven studies that examined five talking therapies among 825 people with drug problems.
Cognitive-behavioural coping skills training (CBCST) is a talking therapy that focuses on changing the way people think and act.
The twelve-step programme is based on theories from Alcoholics Anonymous and aims to motivate the person to develop a desire to
stop using drugs or alcohol.
Motivational interviewing (MI) helps people to explore and resolve doubts about changing their behaviour. It can be delivered in group,
individual and intensive formats.
Brief motivational interviewing (BMI) is a shorter MI that takes 45 minutes to three hours.
Brief interventions are based on MI but they take only five to 30 minutes and are often delivered by a non-specialist.
Six of the studies were funded by the National Institutes for Health or by the Health Research Board; one study did not report its
funding source.
Key results
We found that the talking therapies led to no differences, or only small differences, for the outcomes assessed. These included abstinence,
reduced drinking, and substance use.
One study found that there may be no difference between CBCST and the twelve-step programme.
Three studies found that there may be no difference between brief intervention and usual treatment.
Three studies found that there may be no difference between MI and usual treatment or education only.
One study found that BMI is probably better at reducing alcohol use than usual treatment (needle exchange), but found no differences
in other outcomes.
One study found that intensive MI may be somewhat better than standard MI at reducing severity of alcohol use disorder among
women, but not among men and found no differences in other outcomes.
It remains uncertain whether talking therapies reduce alcohol and drug use in people who also have problems with other drugs. High-
quality studies are missing and are needed.
Quality of evidence
The quality of the evidence was moderate for brief and intensive motivational interviewing, but low for brief interventions and standard
motivational interviewing, and very low for CBCST versus twelve-step programme.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Cognitive-behavioural coping skills training (CBCST) compared to twelve-step facilitation (TSF) programme to reduce alcohol consumption in PWID
Patient or population: concurrent problem alcohol and illicit drug users
Setting: substance use treatment centre
Intervention: cognit ive-behavioural coping skills training (CBCST)
Comparison: twelve-step facilitat ion (TSF) programme
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with twelve-step
facilitation (TSF) pro-
gramme
Risk with cognitive-be-
havioural coping skills
training (CBCST)
Maximum number of
weeks of consecut ive
alcohol abst inence dur-
ing treatment
assessed with: Sub-
stance abuse calendar
and breathalyser
Scale f rom: 0 to 12
Follow-up: 12 weeks
The mean maximum
number of weeks of
consecut ive alcohol ab-
st inence during treat-
ment was 1.8 weeks
MD 0.4 weeks higher
(1.14 lower to 1.94
higher)
- 41
(1 RCT)
⊕©©©
VERY LOW 12
Number of part icipants
achieving 3 or more
weeks of consecut ive
alcohol abst inence dur-
ing treatment
assessed with: Sub-
stance abuse calendar
and breathalyser
Follow-up: 1 year
Study populat ion RR 1.96
(0.43 to 8.94)
41
(1 RCT)
⊕©©©
VERY LOW 12
111 per 1,000 218 per 1,000
(48 to 993)
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Alcohol abst inence
assessed with: Sub-
stance abuse calendar
and breathalyser
Follow-up: 1 year
Study populat ion RR 2.38
(0.10 to 55.06)
41
(1 RCT)
⊕©©©
VERY LOW 12
0 per 1,000 0 per 1,000
(0 to 0)
Retent ion - end of treat-
ment
Assessed with: num-
ber of part icipants com-
plet ing all t reatment
sessions
Study populat ion RR 0.89
(0.62 to 1.29)
41
(1 RCT)
⊕©©©
VERY LOW 12
778 per 1,000 692 per 1,000
(482 to 1,000)
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: Conf idence interval; RR: Risk rat io; MD: mean dif ference; PWID: people who use illicit drugs
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Downgraded one level for risk of bias: incomplete outcome data.
2 Downgraded two levels for imprecision: only one study with very few part icipants included in comparison.
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B A C K G R O U N D
Description of the condition
Problem alcohol use is common among people who use illicit
drugs (PWID) and is associated with adverse health outcomes,
which have physical, psychological and social implications (Staiger
2013). Meta-analyses of US clinical trial data, performed by the
National Institute on Drug Abuse (NIDA), found alcohol use dis-
orders (AUDs) in 38% and 45% of opiate- and stimulant-using
treatment seekers, respectively (Hartzler 2010; Hartzler 2011).
The prevalence of ’heavy drinking’ or diagnosis of alcohol use dis-
order among PWID enrolled in methadone maintenance treat-
ment (MMT) ranges from 13% to 28% (Chen 2011; Klimas
2015a; Klimas 2017b). In comparison, cross-sectional studies have
reported prevalence rates of 33% to 50% in this setting (Islam
2013;Wurst 2011). Another study found that 28% of heroin users
and methadone- or codeine-maintained patients consumed more
than 40g of alcohol daily (Backmund 2003).
Problem alcohol use is an expression that represents a spectrum of
distinct drinking patterns (i.e. hazardous, harmful and dependent
drinking). Hazardous drinking “is likely to result in harm should
present habits persist” (Babor 2001), whereas harmful drinking,
which is a diagnosis given in the International Classification of
Diseases, Tenth Revision (ICD-10) (WHO 1993), “causes harm
to the health (physical or mental) of the individual” without the
presence of dependence (Babor 2001). Hazardous drinking that
becomes severe is assigned the medical diagnosis of alcohol use
disorder (AUD) under the Diagnostic and Statistical Manual of
Mental Disorders, Fifth Edition (DSM-5), or ICD-10 criteria (
WHO1993). Eleven diagnostic criteria describe theDSM-5AUD
diagnosis, which is determined by the presence of any two of the
11 criteria during the last year. Based on the number of criteria
fulfilled, an AUD can be mild (2 to 3), moderate (4 to 5) or severe
(more than 6). According to the National Institute on Alcohol
Abuse and Alcoholism, “binge drinking” refers to a pattern of
drinkingwherein blood alcohol level is regularly at or above 0.08%
(NIAAA 2004). This corresponds to five or more standard drinks
inmales and four ormore drinks in females within an approximate
two-hour period.
In PWID, binge drinking is associated with increased all-cause
mortality (Johnson 2015), while daily drinking is associated with
increased incidence of HIV seroconversion (Young 2016). In
addition, problematic alcohol use in PWID is associated with
unsafe sex, incarceration, and the use of more than one drug
(Maynié-François 2016). Alcohol use in PWID is also associated
with increased risk of fatal overdose (Shah 2008); however, heavy
drinking is not associated with all-cause or overdose mortality
among people receiving opioid agonist treatment (OAT) (Klimas
2017a). PWID are at high risk of liver disease resulting from hep-
atitis C virus infection because of its high prevalence in this pop-
ulation (Smyth 1998). Problem alcohol use is an important fac-
tor contributing to a poor prognosis among people with hepati-
tis C virus as it impacts on progression to hepatic cirrhosis, in-
creased hepatitis C virus-RNA levels or fatal opiate overdose in
opiate users (Du 2012; White 1999). However, alcohol may have
little influence on response to hepatitis C treatment (Tsui 2017).
Nevertheless, Teplin and colleagues noted that PWID have higher
rates of mood, anxiety and personality disorders, all of which are
exacerbated by alcohol use (Teplin 2007).
There exists some evidence that alcoholmay have a negative impact
on outcomes of substance-use disorder treatment (Byrne 2011;
Gossop 2000). For example, a study of 114 participants enrolled
in OAT found that drinking was associated with heroin and co-
caine craving and actual use (Preston 2016). Sadly, in some coun-
tries substance-use disorder treatment programmes do not accept
patients with AUDs who are receiving OAT, because this is viewed
as a violation of their “drug free” policies (Harris 2010). However,
these precautions diminish patients’ access to treatment and are
not justified, nor evidence-based, as shown in previous demon-
stration projects (Kipnis 2001). In PWID, initiation of OAT de-
creases initiation of heavy drinking (Klimas 2016). While short-
term OAT (four weeks’ duration) decreases alcohol consumption
(Caputo 2002), longer-term OAT (two years’ duration) has been
shown to increase alcohol consumption, potentially as a substitute
substance (Dobler-Mikola 2005).
The emerging understanding of a high prevalence of problem alco-
hol use among current or former PWID, allied to the clear health
implications of this problem for this population, necessitates a
public health response to this issue.
Description of the intervention
Psychosocial interventions are best described as “psychologically-
based interventions aimed at reducing consumption behaviour or
alcohol-related problems” (Anderson 2004; Kaner 2018), that ex-
clude any pharmacological treatments. The term refers to a het-
erogeneous collection of interventions, which vary depending on:
• theoretical underpinnings (e.g. psychodynamic,
behavioural, motivational);
• duration or intensity (e.g. brief, extended);
• setting (e.g. primary-care based, inpatient);
• mode of delivery (e.g. group, individual, web-based); or
• treatment goals (e.g. abstinence oriented, harm reduction).
To date, many psychosocial interventions specifically designed
to address problem alcohol use have been described. The most
frequently used interventions include: motivational interviewing
(MI), cognitive-behavioural therapy (CBT), psychodynamic ap-
proaches, screening and brief interventions (SBIs), family therapy,
drug counselling, 12-step programmes, therapeutic community
(TC) and vocational rehabilitation (VR).
• MI is a client-centred approach, but in contrast to its non-
directive Rogerian origins, it is a directive therapy system. A
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central role is played by the client’s motivation and readiness to
change. Change within this approach is facilitated over a series of
stages (Prochaska 1992). Relapse is not viewed as a failure to
maintain healthy behaviour, but rather as a part of the process of
change (Miller 2004).
• CBT draws upon the principles of learning theory. Change
in addictive behaviour is approached through altering irrational
assumptions, coping skills training or other behavioural
exercises. This therapy often deals with the identification and
prevention of triggers contributing to drug use. Among the
modern approaches utilising such behavioural techniques are
Relapse Prevention (Marlatt 1996), Contingency Management
(Budney 2001), and the Community Reinforcement Approach,
which combines both contingency management and positive
reinforcement for non-drinking behaviours (Hunt 1973).
• Psychodynamic approaches are based on the assumptions of
psychoanalytic theory, which focuses on addressing inner
conflict, childhood trauma or problematic relationship themes.
Such approaches include a range of different methods designed
to deal with the underlying conflict (e.g. interpersonal therapy,
supportive-expressive techniques, etc.) (Crits-Christoph 1999).
• SBIs are time limited and therefore suitable for non-
specialist facilities. Usually, the length and intensity of the
intervention is determined by the levels of risky alcohol
consumption (i.e. screening results), and can range from a couple
of minutes to several sessions (three to six). Each session includes
the provision of information and advice (Babor 2001).
Increasingly, brief interventions (BIs) are based on the principles
and techniques of MI, so that the distinction between these two
modalities is blurred in this regard.
• Family therapy: the therapeutic change is achieved via
intervening in the interaction between family members. Families
are directly involved in a therapy session. The family therapist
must be competent in eliciting the strengths and support of the
wider family system. Frequently used family therapy models
include multisystemic therapy and network therapy solution-
focused brief therapy (CSAT 2004).
• Drug counselling: addiction is viewed as a chronic illness
that has serious consequences to the individual’s health and social
functioning, in consonance with the 12-step model (see below).
Recovery includes spiritual components and attendance at
fellowship meetings. The primary focus of this approach is to
help the individual attain abstinence by promoting behavioural
changes, including trigger avoidance, sport and other
constructive activities. Both individual and group forms of drug
counselling have been used in the largest collaborative cocaine
treatment study (Crits-Christoph 1999).
• The 12-step (facilitation) model emphasises the
powerlessness of an individual over the addiction, which is seen
as a disease, and the need for a spiritual recovery. The
foundations of this approach lie in the 12 Steps and an
accompanying document, 12 Traditions (Alcoholics Anonymous
1939). The largest of all 12-step programmes is that of Alcoholics
Anonymous (AA), and all other programmes (e.g. those of
Narcotics Anonymous, Al-Anon etc.) have evolved from it. AA
meetings, besides the 12 steps, utilise well-established therapeutic
factors of group psychotherapy, such as group cohesiveness,
interpersonal learning (i.e. sponsorship), peer pressure, etc.
• TC is a long-term (18- to 24-month), drug-free model of
treatment, which usually runs in a residential form. This
approach relies on the community itself, as the main therapeutic
factor, and also on other factors, such as peer feedback, role-
modelling or recapitulation of the primary family experience.
The community has a high degree of autonomy, is democratic
and each member has a clearly defined role and responsibilities
within the structure of TC. A structured regimen of daily
activities in the TC often includes formal individual or group
therapy sessions along with other educational and work activities
(De Leon 2000; Staiger 2009).
• VR employment is seen as an important element of
successful rehabilitation from drug addiction and is often
considered as one of its key indicators (Platt 1995). VR aims to
increase the employability of PWID by developing their job
interview skills or obtaining further qualifications. A necessary
part of increasing ex-users’ access to the job market is linking
with potential employers and addressing their concerns and
prejudices related to PWID. An example of VR for unemployed
individuals receiving methadone maintenance treatment is the
customised employment supports model (Blankertz 2004).
How the intervention might work
Substantial evidence has described the value of psychosocial inter-
ventions in treating problem alcohol use.
A review by Raistrick and colleagues presented data on the effec-
tiveness ofmany interventions, including screening, further assess-
ment, BIs, more intensive treatments that can still be considered
’brief ’ and alcohol-focused specialist treatments (Raistrick 2006).
They reported mixed evidence on the longer-term effects of BIs
and whether extended BIs add anything to the effects of simple
BIs.
The Mesa Grande project, which reviewed 361 controlled clini-
cal trials (CCTs) (a three-year update), found BIs to be the most
strongly supported psychosocial treatment effective in treating
AUDs (Miller 2002). These findings are supported by an Aus-
tralian systematic review that found BIs to be effective in reduc-
ing alcohol consumption in drinkers without dependence or those
with a low level of dependence (Shand 2003). Another meta-anal-
ysis found the positive effect of BIs to be evident at the follow-up
points of three, six and 12 months, and these results were more
apparent when dependent drinkers were excluded (Moyer 2002).
Indeed, dependent drinkers have been excluded from much of
this research, indicating that they are possibly unsuitable for BI
7Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
and should be routinely referred to specialist treatment (Raistrick
2006).
While BIs are generally delivered across a range of settings, primary
care has an important role in the delivery of BIs for problemalcohol
use among PWID. BIs are well suited to primary care owing to
their feasibility and ease of delivery in general settings by non-
specialist staff in a short period of time, and to individuals not
actively seeking treatment (Kaner 2018; Raistrick 2006; Williams
2011). While primary care physicians believe these interventions
are feasible, many face challenges incorporating them into care
and often underestimate problem alcohol use in this population
(McCombe 2016). In particular, patients receiving methadone
maintenance treatment in primary care settings are not routinely
screened for alcohol (Klimas 2015b).
The efficacy of primary care-based interventions for people with
problem alcohol use has been demonstrated in a Cochrane Review
(Kaner 2018), although the authors judged the evidence as being
of moderate quality and reported that longer counselling duration
probably had little additional effect. Another systematic review of
brief, multi-contact behavioural counselling among adults attend-
ing primary care reported an average reduction of 13% to 34% in
drinks per week (Whitlock 2004).However, a recentmeta-analysis
of studies of adolescents and young adults showed that brief, al-
cohol-targeted interventions decreased alcohol consumption, but
had no effect on illicit drug use. In comparison, the same inter-
vention targeted at alcohol and drugs decreased both behaviours
(Tanner-Smith 2015). Therefore, the evidence behind brief inter-
ventions for illicit drug use appears inconclusive (Saitz 2014).
There have also been new pilot studies published of psychosocial
interventions for hazardous alcohol use among persons receiving
OAT. One study found 88% of participants attempted to reduce
their alcohol intake after the sessions, while 57% significantly re-
duced their alcohol use (Varshney 2016). Another study, Rosa
2015, also found a significant decrease in alcohol consumption
after the intervention. Finally, an educational intervention to sup-
port primary care of problem alcohol use among PWID has been
developed and process-evaluated (Klimas 2014).
Thus, brief psychosocial interventions are feasible and potentially
highly efficacious components of an overall public health ap-
proach to reducing problem alcohol use, although there is consid-
erable variation in trials of effectiveness, and PWID from primary
care settings are under-represented in these trials (Kaner 2018;
Whitlock 2004).
Because BIs have been developed and evaluatedmainly in conven-
tional general practice settings, it is not clear whether they can be
effectively applied to excessive drinking among PWID, or whether
new forms of intervention need to be developed and evaluated.
Could the ’advice-giving’ form of BI be effective in PWID or are
motivational techniques, in which the impetus for change comes
from the user, more likely to be effective in this population?
Why it is important to do this review
The high prevalence and serious consequences of problem alcohol
use among PWID highlights an opportunity for a Cochrane sys-
tematic review in this population. The question being asked in this
review is also of importance because there are no other systematic
reviews published that could help answer it.
Several narrative literature reviews have dealt with this question
to date. The oldest of these reviews discussed six reports of four
studies among methadone patients and saw some promise for con-
tingency management procedures (Bickel 1987). A more recent
review described the implications of combining behavioural and
pharmacological treatments, which are effective in treating either
alcohol- or drug-use disorders alone, for the treatment of people
who have both these disorders (Arias 2008).While pointing to the
paucity of research specifically focused on the treatment of people
with co-occurring alcohol and other substance use disorders, the
review concluded that successful treatment must take into account
both alcohol- and drug-use disorders. Similarly, a review on treat-
ment of people seeking therapy primarily for alcohol problems,
but who also used other drugs, concurred with this idea (Miller
1996). More recently, two narrative reviews examined the patterns
of concurrent use among people in and out of the treatment for
substance use disorders (Staiger 2013; Soyka 2015). Both reviews
(Staiger 2013; Soyka 2015) concluded that while concurrent al-
cohol use is often “overlooked and underestimated” in drug treat-
ment, no clear patterns have emerged and the literature remains
inconclusive. Another narrative review calls for creation of a set
of guidelines for screening and treatment of alcohol use in OAT
participants, based on the high prevalence of problem alcohol use
and limited alcohol treatment access in this patient population
(Nolan 2016). It also concluded that there is no clinical evidence
to justify denial of treatment for alcohol use disorders, or reduc-
tion of opioid agonist dose, in OAT participants.
Cochrane Reviews have so far examined the effectiveness of psy-
chosocial interventions for stimulant, opiate and alcohol use dis-
orders (Amato 2011a; Minozzi 2016; Lui 2008). Although other
reviews and review protocols have targeted poly-drug use, they
concentrated either on specific populations, for example women
and adolescents, or particular interventions, such as case manage-
ment and MI, but not on ’alcohol-specific’ interventions (Dalsbø
2010; Hesse 2007; Smedslund 2011; Smith 2006; Terplan 2015;
Thomas 2011). None of the published reviews on psychosocial
interventions examined the effectiveness of alcohol-specific inter-
ventions in PWID. The main problem driving the lack of quality
studies in this area seems to flow from the administrative separa-
tion of drug problems from alcohol problems. This separation has
led researchers to focus on one or the other but not on both. In the
USA, the National Institutes of Health had planned to correct this
separation by forming a new institute that covers both drugs and
alcohol - the proposed National Institute of Substance Use and
Addiction Disorders (NIH 2012) - although this plan was quickly
abandoned.
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The lack of systematic evaluation, together with the anticipated
differences in the responsiveness of PWID to psychosocial inter-
ventions, provides additional reasons for conducting this review. In
other words, the results of reviews on the effectiveness of psychoso-
cial interventions among the general population might not be ap-
plicable to specific groups, such as PWID, because they may have
a different responsiveness to psychosocial interventions (Nilsen
2010; Klimas 2012b). Several factors could possibly influence the
responsiveness of PWID to treatment interventions (for example,
stability of drug use, engagement with the service, concurrent per-
sonality disorders, etc). Evidence suggests that PWID with antiso-
cial personality disorders are more likely to respond to rewarding
than to punitive approaches (Messina 2003), and the use of more
intensive psychosocial interventions is recommended in those who
have achieved a sufficient degree of stability and compliance with
a service regimen (Pilling 2010; Saitz 2015).
Moreover, it has been suggested that evidence on the effectiveness
of many psychosocial interventions has been overestimated, that
limitations of this evidence have been overlooked, and that results
are difficult to generalise (McCambridge 2017). These criticisms
further highlight the necessity of a comprehensive systematic re-
view evaluating and consolidating the body of literature on various
psychosocial interventions in PWID.
O B J E C T I V E S
To assess the effectiveness of psychosocial interventions to reduce
alcohol consumption inpeoplewhouse illicit drugs (PWID) (users
of opioids and stimulants).
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) and controlled
clinical trials (CCTs).
Types of participants
We included people who use illicit drugs (PWID), aged 18 years or
more, attending a range of services (i.e. community, inpatient or
residential, including receiving opioid agonist treatment). Problem
drug use was defined according to the definition of the European
Monitoring Centre for Drugs and Drug Addiction, as “injecting
drug use or long-duration/regular use of opioids, cocaine and/
or amphetamines” (EMCDDA 2008, page 10). This definition
also encompasses other similar terms, for example substance use,
misuse, abuse, dependence, addiction or people who use illicit
drugs.
Only studies that defined participants as problemdrug and alcohol
users at randomisation were included. Studies including PWID
without concurrent problem alcohol use were excluded. We ex-
cluded participants whose primary drug of use was alcohol.
Types of interventions
Experimental interventions: any psychosocial intervention that
was described by the study’s author(s) as such.
Control interventions: other psychosocial interventions that al-
lowed for comparisons between different types of interventions
(e.g. CBT, contingency management, family therapy, etc.), stan-
dard care, no intervention, waiting list, or any other non-pharma-
cological therapy, including moderate drinking, assessment-only.
We intended to exclude studies comparing psychosocial with phar-
macological treatments. However, trials with two psychosocial
arms in addition to pharmacological arms were exempted from
this rule.
Types of outcome measures
Primary outcomes
1. Alcohol use (reduction or stabilisation), as measured by
either biological markers or self-report tests
2. Retention in treatment (measured as number of people
completing all treatment sessions, or retained at three months -
for studies of brief interventions)
Secondary outcomes
1. Illicit drug use (changes in illicit drug use), as measured by
either biological markers or self-report tests
2. Alcohol-related problems or harms, as represented by
physical or mental health outcomes associated with problem
alcohol use.
Search methods for identification of studies
Electronic searches
For this second update of a previously published review update,
we searched the following databases up to 3 August 2017.
• Cochrane Drugs and Alcohol Review Group (CDAG)
Specialised Register* (June 2014 to August 2017; 20 hits)
• Cochrane Central Register of Controlled Trials
(CENTRAL, July 2017, Issue 7) in the Cochrane Library
• MEDLINE (PubMed) (June 2014 to August 2017)
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• Embase (Elsevier) (June 2014 to August 2017)
• CINAHL EBSCO (June 2014 to August 2017)
• PsycINFO (ProQuest) (June 2014 to August 2017)
* All trials from the CDAG Specialised Register can be found in
the Cochrane Library by searching on SR-ADDICTN.
Details of the previous search strategies are available in the previ-
ously published updates (Klimas 2012a; Klimas 2014b).
We searched the databases using a strategy developed incorporat-
ing the filter for the identification of RCTs (Higgins 2011), com-
bined with selected medical subject heading (MeSH) terms and
free-text terms relating to alcohol use. The CDAG Information
Specialist conducted the electronic searches of all the databases
listed above except PsycINFO, which the first author of the review
conducted. We adapted the MEDLINE search strategy for use
with the other databases using the appropriate controlled vocabu-
lary, as applicable. Since the initial search yielded several RCTs, we
continued to use the RCT filter for subsequent database searches.
We collated the results of the two sets of electronic searches into a
single EndNote database.
The search strategies for all databases are shown in Appendix 1,
Appendix 2, Appendix 3, Appendix 4 and Appendix 5.
For the 2017 update, we searched for ongoing clinical trials and
unpublished studies via searches on the following websites:
1. www.controlled-trials.com (search date: 17 May 2017);
2. www.clinicaltrials.gov (search date: 17 May 2017);
3. www.centrewatch.com (search date: 17 May 2017);
4. World Health Organization International Clinical Trials
Registry Platform, www.who.int/ictrp/en/ (search date: 17 May
2017).
Searching other resources
We also searched:
1. reference lists of articles considered eligible based on full
report screening and other relevant papers;
2. conference proceedings (online archives only) of the Society
for the Study of Addiction, International Harm Reduction
Association, International Conference on Alcohol Harm
Reduction and American Association for the Treatment of
Opioid Dependence.
In addition, we contacted investigators and relevant trial authors
seeking information about unpublished or incomplete trials.
All searches included non-English language literature and we as-
sessed any with English abstracts for inclusion. When we con-
sidered the studies likely to meet inclusion criteria, we obtained
translations of any abstracts.
Data collection and analysis
Selection of studies
Two review authors (JK, ChF) independently screened titles and
abstracts and selected studies potentially relevant.We resolved any
differences between selection lists by discussion with a third and
fourth review author with respective thematic and methodolog-
ical expertise (WC, CSMOG). We obtained full-text copies of
each potentially relevant paper, as well as full reports of references
with inadequate information in order to definitively determine
relevance. Two review authors (JK, ChF) independently re-evalu-
ated whether studies were eligible for the update or not, accord-
ing to the inclusion criteria. A second opinion was not needed.
We screened abstracts, full texts and extracted data using the Eppi
Reviewer 4 software (Eppi 2017).
Data extraction and management
Two review authors (JK, ChF) independently extracted data from
the full-text reports using an electronic version of an amended data
extraction formof theCochraneDrug andAlcohol ReviewGroup.
We resolved disagreements bymutual discussion.We sought infor-
mation on study participants, characteristics of experimental and
control intervention, primary and secondary outcomes, funding
and conflict of interest from reports of included studies.
Assessment of risk of bias in included studies
Weperformed ’Risk of bias’ assessments for RCTs and CCTs using
the criteria recommended in theCochrane Handbook for Systematic
Reviews of Interventions (Higgins 2011). The recommended ap-
proach for assessing risk of bias in studies included in a Cochrane
Review is a two-part tool addressing six specific domains (namely
sequence generation, allocation concealment, blinding of partic-
ipants and personnel, blinding of outcome assessor, incomplete
outcome data and selective outcome reporting). The first part of
the tool involves describing what was reported to have happened
in the study. The second part of the tool involves assigning a judge-
ment relating to the risk of bias for that entry in terms of high,
low or unclear risk. To make these judgements we used the criteria
indicated in theCochrane Handbook for Systematic Reviews of Inter-
ventions adapted to the addiction field. See the table in Appendix
6 for details.
We addressed the domains of sequence generation and allocation
concealment (avoidance of selection bias) using a single entry for
each study.
Blinding of participants and providers was not possible for this
kind of intervention. Moreover, knowledge of participation in a
psychosocial intervention is part of the therapeutic effect; there-
fore, we think that lack of blinding of participants and person-
nel does not introduce bias in trials of psychosocial interventions.
“In psychotherapy, it is impossible for the principle participants
to be blind to the treatment used.“(Beutler 2016, p.102) For this
reason, we did not assess the risk of performance bias. We con-
sidered the blinding of outcome assessors (avoidance of detection
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bias) separately for objective outcomes (e.g. dropouts from ther-
apy, substance use measured by urinalysis, participants relapsed at
the end of follow-up, participants engaged in further treatments),
and subjective outcomes (e.g. duration and severity of signs and
symptomsofwithdrawal, individual self-reported use of substance,
side effects, social functioning as integration at school or at work,
family relationship, etc.).
We considered incomplete outcome data (avoidance of attrition
bias) for all outcomes with the exception of dropouts from ther-
apy, which is usually the primary outcome measure in trials on
addiction. We assessed this separately for results at the end of the
study period, and for results at follow up.
Measures of treatment effect
For continuous data, we calculated mean differences (MDs), and
standardised MDs (where appropriate) between the intervention
and comparator groups, with 95% confidence intervals (CIs). We
present dichotomous outcomes as risk ratios (RRs), with 95%CIs.
Unit of analysis issues
We included only one multiarm trial, Nyamathi 2010, in the re-
view and it was not included more than once in any of the com-
parisons. This study had three arms; of those, two were experi-
mental (group and single format). We collapsed them into a single
experimental group which we entered into a single comparison so
they were not counted twice.
In accordance with the Cochrane Handbook (Higgins 2011), the
actual sample sizes of included cluster-randomised trials have been
reduced by a design effect coefficient to their effective sample size.
Dealing with missing data
We contacted the authors of the seven original studies by email for
missing data (April 2012; July 2016) and sent reminders after two
weeks. To date, five study authors have responded and provided
additional information.
Assessment of heterogeneity
We analysed heterogeneity by using the I² statistic and the Chi²
test. Cut-off points included an I² value greater than 50% and a
P value for the Chi² test less than 0.1.
Assessment of reporting biases
We planned to further explore the potential for reporting bias
using funnel plots if more than 10 RCTs were included (plotting
the effect from each trial against the sample size or effect’s standard
error); however, this was not possible because only seven RCTs
were identified.
Data synthesis
For comparisons of sufficiently similar studies, we used the ran-
dom-effects model. For the comparisons where we considered that
no two studies were sufficiently similar to allow pooling of data,
we reported the results of included studies individually for each
trial. We used a xed-effect model if there was only one trial for
each comparison.
Subgroup analysis and investigation of heterogeneity
If sufficient information had been available, we had planned to
conduct the following subgroup analyses:
1. types of psychosocial intervention (e.g. motivational versus
behavioural or brief interventions);
2. length of the intervention (short, medium, extended).
We had also intended to conduct the following subgroup analyses,
but did not due to there being insufficient data:
1. sustained benefit at six and 12 months after intervention;
2. gender differences;
3. single-drug (alcohol) versus poly-drug-focused
interventions;
4. single-drug (alcohol) versus poly-drug-focused
interventions that also address other health-related behaviours.
Sensitivity analysis
If sufficient information had been available, we intended to con-
duct the following sensitivity analyses according to the following
criteria:
• excluding studies with a high risk of bias from the analysis:
this decision was to be based on a predefined cut-off score (i.e.
studies judged to be at high risk of bias for three or more
domains, including selection bias, were to be excluded);
• excluding CCTs.
However, we did not perform sensitivity analyses because of in-
sufficient information.
’Summary of findings’ tables
We assessed the overall quality of the evidence for the primary
outcomes using the GRADE system for grading the quality of
evidence (Schunemann 2013), which takes into account issues not
only related to internal validity but also to external validity, such
as directness, consistency, imprecision of results and publication
bias. The ’Summary of findings’ tables present themain findings of
a review in a transparent and simple tabular format. In particular,
they provide key information concerning the quality of evidence,
themagnitude of effect of the interventions examined and the sum
of available data on the main outcomes.
TheGRADE systemuses the following criteria for assigning grades
of evidence.
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• High quality: we are very confident that the true effect lies
close to that of the estimate of the effect.
• Moderate quality: we are moderately confident in the effect
estimate. The true effect is likely to be close to the estimate of the
effect, but there is a possibility that it is substantially different.
• Low quality: our confidence in the effect estimate is
limited. The true effect may be substantially different from the
estimate of the effect
• Very low quality: we have very little confidence in the effect
estimate. The true effect is likely to be substantially different
from the estimate of effect.
Grading of the quality of evidence is decreased for the following
reasons.
• Serious (-1) or very serious (-2) study limitations due to risk
of bias.
• Serious (-1) or very serious (-2) inconsistency between
study results.
• Some (-1) or major (-2) uncertainty about directness (the
correspondence between the population, the intervention, or the
outcomes measured in the studies actually found and those
under consideration in our systematic review).
• Serious (-1) or very serious (-2) imprecision of the pooled
estimate.
• Publication bias strongly suspected (-1).
Consumer participation
We sought consumer participation in the preparation of the pro-
tocol and the original review: a) the first review author (JK) is a
member of the Cochrane Consumers Network, b) the Cochrane
Consumers Network was approached to assist with the plain lan-
guage summary of the review, and c) one of the co-authors of
this review (EK) contributed to consumer consultation during the
protocol and review development, as he was a practicing clinician
in a healthcare facility with a high prevalence of this problem.
R E S U L T S
Description of studies
See Characteristics of included studies, Characteristics of excluded
studies and Characteristics of studies awaiting classification.
Results of the search
This is an update of a Cochrane Review first published in 2012
(Klimas 2012a), and updated in 2014 (Klimas 2014b). In the first
version of our review, we retrieved a total of 7207 records from the
initial search of the Cochrane Drugs and Alcohol Review Group
(CDAG) Register, the Cochrane Central Register of Controlled
Trials (CENTRAL), PubMed, Embase, CINAHL and PsycINFO.
Removing duplicates left 5548 records. After screening titles and
abstracts, we identified 25 potentially eligible studies; we excluded
18 full-text reports and included seven reports which described
four randomised controlled trials (RCTs). We found no additional
studies through reference checking.
For the 2014 update, we retrieved a total of 1836 records from
a more up-to-date search of the CDAG Register, CENTRAL,
PubMed, Embase, CINAHL and PsycINFO. Removing dupli-
cates left 960 records. After screening titles and abstracts we iden-
tified 16 potentially eligible records and included one record
(Feldman 2013). This record was a 2013 correction of Feldman
2013, a paper we included in the first version of this review (Klimas
2012a).
For this 2017 update, we retrieved a total of 3503 records from
a more up-to-date search of the CDAG Register, CENTRAL,
PubMed, Embase, CINAHL and PsycINFO. We identified one
additional study through other sources. Removing duplicates left
921 records. After screening titles and abstracts we identified 17
potentially eligible studies; we excluded 14 full-text reports and
included three new RCTs (Darker 2016; Feldman 2013; Henihan
2016). Four studies are awaiting classification (Aharonovich 2017;
Poblete 2017; Staiger 2009; Thapaliya 2017). A PRISMA (Moher
2009) flowchart of study selection for this review update is shown
in Figure 1.
12Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 1. Study flow diagram for the 2017 review update: previous studies incorporated into results of new
literature search
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Included studies
We included seven studies (825 participants) in this review.
Study designs
Five studieswere parallel RCTs and twowere cluster-RCTs (Darker
2016; Henihan 2016)
Participants
Participants included 825 people who use illicit drugs (PWID).
Onemultiarm trial included122participants (Carroll 1998), how-
ever, from this study only 41 participants from two psychosocial
therapy arms were considered for this review. The mean age of
participants was 38.6 years, and 28% were female.
Intervention
The studies assessed the effectiveness of eight psychosocial inter-
ventions: cognitive-behavioural coping skills training (CBCST),
twelve-step facilitation (TSF) programme, brief intervention (BI),
motivational interviewing (MI) (group based), MI (individual),
educational hepatitis health promotion (HHP), brief motivational
interviewing (BMI), and MI (intensive, group based). CBCST
and TSF involved 16 individual sessions, twice weekly, over 12
weeks. BI involved one session that lasted approximately 15 min-
utes. MI (group and single) and HHP were delivered over three
60-minute sessions, spaced two weeks apart. BMI included two
therapist sessions, one month apart; the first session was 60 min-
utes long and the second session was 30 to 45 minutes long. MI
(intensive, group based) involved a total of nine 50-minute ses-
sions, with three sessions being delivered each week (versus one
90-minute session of standard MI and eight 60-minute nutrition
sessions).
Types of comparisons and setting
• CBCST versus TSF in an outpatient clinic (Carroll 1998)
• BI versus treatment as usual in an opioid agonist clinic
(Darker 2016)
• BI versus treatment as usual in an outpatient clinic with/
without opioid agonist treatment (Feldman 2013)
• BI versus treatment as usual in a primary care setting
(Henihan 2016)
• MI versus HHP in an opioid agonist clinic (Nyamathi
2010)
• BMI versus assessment-only in a needle exchange
programme (Stein 2002)
• MI intensive (group) versus MI (group) in an outpatient
substance use treatment facility (Korcha 2014)
Country
Four studies were conducted in the USA, two in Ireland, and one
in Switzerland.
Duration of the trials
Duration of the trials ranged from one to 12 weeks (mean 3.9
weeks), plus various follow-ups. Between one and 16 sessions were
offered to participants (mean 4.7, providing from three minutes
to 16 hours of treatment time).
Funding
Six of the studies were funded by theNational Institutes forHealth
or by the Health Research Board; one study did not report its
funding source. Four studies reported no competing interests (
Darker 2016; Feldman 2013; Henihan 2016; Nyamathi 2010),
while three studies did not provide information about conflicts of
interests (Carroll 1998; Korcha 2014; Stein 2002).
See the Characteristics of included studies table for more details.
Excluded studies
We excluded 46 studies (17 in 2012, 15 in 2014, and 14 in 2017)
that did not meet the criteria for inclusion in this review; for more
information see the Characteristics of excluded studies table.
We considered grounds for exclusion as follows: type of interven-
tion not in the inclusion criteria (no studies); type of participants
not in the inclusion criteria (37 studies); types of outcomes not in
the inclusion criteria (six studies); study design not in the inclu-
sion criteria (three studies).
Risk of bias in included studies
All the studies were RCTs. For a summary of the our judgements
regarding risk of bias for each domain in each included study and
across studies, see Figure 2 and Figure 3. See the Characteristics
of included studies table for more detailed information.
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Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
Random sequence generation
We judged random sequence generation to be adequate in three
studies (for two studies, this was based on unpublished informa-
tion obtained via email communication with the study authors),
and unclear in the remaining trials.
Allocation concealment
We judged three studies as being at low risk of bias, and the re-
maining trials as having unclear risk of bias.
Blinding
Detection bias
Objective outcomes
None of the included studies reported objective outcomes, so we
did not assess risk of detection bias for these outcomes.
Subjective outcomes
We assessed the following outcome for this ’Risk of bias’ domain:
abstinence or use of a substance, as measured by self-reported
or interviewer-administered questionnaires. Two studies (27%)
specified that outcome assessors were blinded and we judged these
studies to be at low risk of bias. Four studies reported that the
outcome assessor was not blinded andwe judged these to be at high
risk of bias; for two of them, this was unpublished information
obtained via email communication with the study authors. We
judged one study to have an unclear risk of bias because it did not
specify the blindness of outcome assessor.
Incomplete outcome data
End-of-study outcomes
With the exception of retention in treatment, four studies mea-
sured end-of-study outcomes. We judged three to be at low risk of
bias because of low or balanced dropout rates across all groups. We
judged one study to be at high risk of bias because the dropout rates
were not balanced across all groups: ”the psychotherapy groups
had significantly lower retention rates than the medication [disul-
firam] groups“ (Carroll 1998), although the difference between
the two psychotherapy arms included in the present review was
not significant (70% versus 78%), see Analysis 1.4.
Follow-up outcomes
With the exception of retention in treatment, we judged six stud-
ies to be at low risk of attrition bias because few participants (less
than 10%) withdrew from the studies, or because there was a high
rate of drop-out but percentages were balanced across intervention
groups, and reasons for withdrawal were provided or authors per-
formed an intention-to-treat (ITT) analysis. We judged one study
to be at high risk of bias because of a high dropout rate that was
unbalanced across groups.
Selective reporting
All studies reported on the primary outcomes pre-specified in the
methods sections of the full reports. See Figure 2 and Figure 3.
Effects of interventions
See: Summary of findings for the main comparison Cognitive-
behavioural coping skills training (CBCST) compared to twelve-
step facilitation (TSF) programme to reduce alcohol consumption
in people who use illicit drugs (PWID); Summary of findings
2 Brief intervention (BI) compared to treatment as usual
(TAU) to reduce alcohol consumption in PWID; Summary
of findings 3 Motivational interviewing (MI) compared to
treatment as usual (TAU) or educational intervention only to
reduce alcohol consumption in PWID; Summary of findings 4
Brief motivational interviewing (BMI) compared to assessment-
only to reduce alcohol consumption in PWID; Summary of
findings 5 Motivational interviewing intensive (MII) compared
to motivational interviewing (MI) to reduce alcohol consumption
in PWID
Wewere unable to pool data for any of the comparisons, except that
of ”brief intervention versus treatment as usual“ and ”motivational
interviewing versus treatment as usual“. We therefore summarise
the results according to the type of psychosocial intervention, with
comparisons of quantitative data where possible. The included
studies used different questionnaires to measure their outcomes
and, for many, the authors did not report post-treatment/follow-
up scores, or they did not state what was considered to represent
mild, moderate and severe categories. This prevented comparison
of results across the studies. See the Characteristics of included
studies table for more detailed information.
We present the effects of the interventions by the comparisons
examined in the primary studies. The primary outcomes of this
review were alcohol use (or abstinence) and retention in treatment.
The main secondary outcome was illicit drug use (or abstinence).
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We were unable to report alcohol-related problems or harms be-
cause they were not measured in the included trials.
1. Cognitive-behavioural coping skills training
(CBCST) versus twelve-step facilitation (TSF)
See: Summary of findings for the main comparison for this com-
parison.
Primary outcomes
1.1 Alcohol abstinence as number achieving three or more
weeks of consecutive alcohol abstinence during treatment
There was no significant difference between CBCST and TSF for
this outcome (risk ratio (RR) 1.96, 95% confidence interval (CI)
0.43 to 8.94; one study, 41 participants (Carroll 1998); very low-
quality evidence), see Analysis 1.1.
1.2 Alcohol abstinence as maximum number of weeks of
consecutive alcohol abstinence during treatment
There was no significant difference between CBCST and TSF
for this outcome (mean difference (MD) 0.40, 95% CI -1.14 to
1.94; one study, 41 participants (Carroll 1998); very low-quality
evidence), see Analysis 1.2.
1.3 Alcohol abstinence during follow-up year
There was no significant difference between CBCST and TSF
for this outcome (RR 2.38, 95% CI 0.10 to 55.06; one study,
41 participants (Carroll 1998); very low-quality evidence), see
Analysis 1.3.
1.4 Retention as number of people who completed all
treatment sessions (unpublished)
There was no significant difference between CBCST and TSF
for this outcome (RR 0.89, 95% CI 0.62 to 1.29; one study,
41 participants (Carroll 1998); very low-quality evidence), see
Analysis 1.4.
Secondary outcomes
1.5 Illicit drug abstinence as maximum number of weeks of
consecutive abstinence from cocaine during treatment
There was no significant difference between CBCST and TSF
for this outcome (MD 0.80, 95% CI -0.70 to 2.30; one study,
41 participants (Carroll 1998); very low-quality evidence), see
Analysis 1.5.
1.6 Illicit drug abstinence as number achieving three or more
weeks of consecutive abstinence from cocaine during
treatment
There was no significant difference between CBCST and TSF
for this outcome (RR 1.10, 95% CI 0.42 to 2.88; one study,
41 participants (Carroll 1998); very low-quality evidence), see
Analysis 1.6.
1.7 Illicit drug abstinence as abstinence from cocaine during
follow-up year
There was no significant difference between CBCST and TSF
for this outcome (RR 0.39, 95% CI 0.04 to 3.98; one study,
41 participants (Carroll 1998); very low-quality evidence), see
Analysis 1.7.
1.8 Alcohol-related harms or problems
There were no data for this outcome.
2. Brief intervention (BI) versus treatment as usual
(TAU)
See Summary of findings 2 for this comparison.
Primary outcomes
2.1 Alcohol use as scores on the Alcohol Use Disorders
Identification Test (AUDIT) or Alcohol, Smoking and
Substance Involvement Screening Test (ASSIST) at three
months
There was no significant difference between BI and TAU for this
outcome (standardised mean difference (SMD) 0.07, 95% -0.24
to 0.37; three studies, 170 participants (Darker 2016; Feldman
2013; Henihan 2016); low-quality evidence), see Analysis 2.1.
2.2 Alcohol use as AUDIT scores at nine months
There was no significant difference between BI and TAU for this
outcome (MD 2.30, 95% CI -0.58 to 5.18; one study, 110 par-
ticipants (Feldman 2013); low-quality evidence), see Analysis 2.2.
2.3 Alcohol use as decreased alcohol use at three months
There was no significant difference between BI and TAU for this
outcome (RR 1.13, 95% CI 0.67 to 1.93; one study, 110 partici-
pants (Feldman 2013); low-quality evidence), see Analysis 2.3.
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2.4 Alcohol use as number of drinks per week at three
months
There was no significant difference between BI and TAU for this
outcome (MD 0.70, 95% CI -3.85 to 5.25; one study, 110 par-
ticipants (Feldman 2013); low-quality evidence), see Analysis 2.4.
2.5 Alcohol use as number of drinks per week at nine months
There was no significant difference between BI and TAU for this
outcome (MD -0.30, 95% CI -4.79 to 4.19; one study, 110 par-
ticipants (Feldman 2013); low-quality evidence), see Analysis 2.5.
2.6 Alcohol use as decreased alcohol use at nine months
There was no significant difference between BI and TAU for this
outcome (RR 1.09, 95% CI 0.62 to 1.92; one study, 110 partici-
pants (Feldman 2013); low-quality evidence), see Analysis 2.6.
2.7 Retention at three months (unpublished and published
data)
There was no significant difference between BI and TAU for this
outcome (RR0.94, 95%CI 0.78 to 1.13; three studies, 170 partic-
ipants (Darker 2016; Feldman 2013; Henihan 2016); low-quality
evidence), see Analysis 2.7.
Secondary outcomes
2.8 Illicit drug use
There were no data for this outcome.
2.9 Alcohol-related harms or problems
There were no data for this outcome.
3. Motivational interviewing (MI) versus treatment as
usual or educational intervention only
See: Summary of findings 3 for this comparison.
Primary outcomes
3.1 Alcohol use as AUDIT or ASSIST scores at three months
There was no significant difference between BI and TAU/educa-
tion for this outcome (SMD 0.04, 95% CI -0.29 to 0.37; two
studies, 141 participants (Darker 2016; Feldman 2013); low-qual-
ity evidence), see Analysis 3.1.
3.2 Alcohol use as AUDIT scores at nine months
There was no significant difference between BI and TAU for this
outcome (MD 2.30, 95% CI -0.58 to 5.18; one study, 110 par-
ticipants (Feldman 2013); low-quality evidence), see Analysis 3.2.
3.3 Alcohol use (unpublished) as number of standard drinks
consumed per day over the last 30 days
There was no significant difference between MI and educational
intervention for this outcome (MD -0.20, 95% CI -1.76 to 1.36;
one study, 225 participants (Nyamathi 2010); low-quality evi-
dence), see Analysis 3.3.
3.4 Alcohol use as number of drinks consumed per week at
three months
There was no significant difference between BI and TAU for this
outcome (MD 0.70, 95% CI -3.85 to 5.25; one study, 110 par-
ticipants (Feldman 2013); low-quality evidence), see Analysis 3.4.
3.5 Alcohol use as number of drinks consumed per week at
nine months
There was no significant difference between BI and TAU for this
outcome (MD -0.30, 95% CI -4.79 to 4.19; one study, 110 par-
ticipants (Feldman 2013); low-quality evidence), see Analysis 3.5.
3.6 Alcohol use as greater than 50% reduction in number of
standard drinks consumed per day over the last 30 days
There was no significant difference between MI and Educational
intervention for this outcome (RR1.01, 95%CI0.77 to 1.31;One
study, 256 participants (Nyamathi 2010); low-quality evidence),
see Analysis 3.6.
3.7 Alcohol abstinence as abstinence from alcohol over the
last 30 days
There was no significant difference between MI and Educational
intervention for this outcome (RR 0.93, 95%CI 0.57 to 1.50; one
study, 256 participants (Nyamathi 2010); low-quality evidence),
see Analysis 3.7.
3.8 Alcohol use as decreased alcohol use at three months
There was no significant difference between BI and TAU for this
outcome (RR 1.13, 95% CI 0.67 to 1.93; one study, 110 partici-
pants (Feldman 2013); low-quality evidence), see Analysis 3.8.
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3.9 Alcohol use as decreased alcohol use at nine months
There was no significant difference between BI and TAU for this
outcome (RR 1.09, 95% CI 0.62 to 1.92; one study, 110 partici-
pants (Feldman 2013); low-quality evidence), see Analysis 3.9.
3.10 Retention at end of treatment
There was no significant difference between MI and educational
intervention for this outcome (RR 0.96, 95%CI 0.87 to 1.06; one
study, 256 participants (Nyamathi 2010); low-quality evidence),
see Analysis 3.10.
3.11 Retention at three months (unpublished and published
data)
There was no significant difference between BI and TAU for this
outcome (RR 0.93, 95% CI 0.60 to 1.43; two studies, 160 partic-
ipants (Darker 2016; Feldman 2013); low-quality evidence), see
Analysis 3.11.
Secondary outcomes
3.12 Illicit drug use (unpublished) as frequency of drug use,
as measured by Addiction Severity Index (ASI drug)
There was no significant difference between MI and educational
intervention for this outcome (MD 0.00, 95% CI -0.03 to 0.03;
one study, 225 participants (Nyamathi 2010); low-quality evi-
dence), see Analysis 3.12.
3.13 Illicit drug use (unpublished) as a composite drug score
(frequency* severity for all drugs taken)
There was no significant difference between MI and educational
intervention for this outcome (MD -0.00, 95% CI -0.34 to 0.34;
one study, 229 participants (Nyamathi 2010); low-quality evi-
dence), see Analysis 3.13.*
*Nyamathi 2010 reported an additional outcome as a change score
for: daily drug use since baseline (past 30 days and six-month re-
call). We do not report this calculated variable here because the
authors provided us with unpublished results of two original vari-
ables that fed into this composite score.
3.14 Alcohol-related harms or problems
There were no data for this outcome.
4. Brief motivational interviewing (BMI) versus
assessment-only control
See Summary of findings 4 for this comparison.
Primary outcomes
4.1 Alcohol use as number of days in the past 30 days with
alcohol use at one month
There was no significant difference between BMI and assessment-
only for this outcome (MD -0.30, 95% CI -3.38 to 2.78; one
study, 187 participants (Stein 2002); moderate-quality evidence),
see Analysis 4.1.
4.2 Alcohol use as number of days in the past 30 days with
alcohol use at six months
There was no significant difference between BMI and assessment-
only for this outcome (MD -1.50, 95% CI -4.56 to 1.56; one
study, 187 participants (Stein 2002); moderate-quality evidence),
see Analysis 4.2.
4.3 Alcohol use as 25% reduction of drinking days in the
past 30 days
There was no significant difference between BMI and assessment-
only for this outcome (RR 1.23, 95% CI 0.96 to 1.57; one study,
187 participants (Stein 2002); moderate-quality evidence), see
Analysis 4.3.
4.4 Alcohol use as 50% reduction of drinking days in the
past 30 days
There was no significant difference between BMI and assessment-
only for this outcome (RR 1.27, 95% CI 0.96 to 1.68; one study,
187 participants (Stein 2002); moderate-quality evidence), see
Analysis 4.4.
4.5 Alcohol use as 75% reduction of drinking days in the
past 30 days
There was no significant difference between BMI and assessment-
only for this outcome (RR 1.21, 95% CI 0.84 to 1.75; one study,
187 participants (Stein 2002); moderate-quality evidence), see
Analysis 4.5.
4.6 Alcohol use as one or more drinking days’ reduction in
the past 30 days
There was no significant difference between BMI and assessment-
only for this outcome (RR 1.12, 95% CI 0.91 to 1.38; one study,
187 participants (Stein 2002); moderate-quality evidence), see
Analysis 4.6.
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4.7 Alcohol use as seven or more drinking days’ reduction in
the past 30 days
There was a significant difference between BMI and assessment-
only for this outcome (RR 1.67, 95% CI 1.08 to 2.60; P = 0.02;
one study, 187 participants (Stein 2002); moderate-quality evi-
dence), see Analysis 4.7.
4.8 Retention as number of people who completed all
treatment sessions
There was no significant difference between BMI and assessment-
only for this outcome (RR 0.98, 95% CI 0.94 to 1.02; one study,
187 participants (Stein 2002); moderate-quality evidence), see
Analysis 4.8.
Secondary outcomes
4.9 Illicit drug use
There were no data for this outcome.
4.10 Alcohol-related harms or problems
There were no data for this outcome.
5. Intensive motivational interviewing (MII) versus
motivational interviewing (MI)
See Summary of findings 5 for this comparison.
Primary outcomes
5.1 Alcohol addiction severity as Addiction Severity Index
alcohol score at two months
There was no significant difference between MII and MI for this
outcome (MD 0.03, 95% CI -0.02 to 0.08; one study, 163 par-
ticipants (Korcha 2014); low-quality evidence), see Analysis 5.1.
5.2 Alcohol addiction severity as Addiction Severity Index
alcohol score at four months
There was no significant difference between MII and MI for this
outcome (MD -0.01, 95% CI -0.06 to 0.04; one study, 163 par-
ticipants (Korcha 2014); low-quality evidence), see Analysis 5.2.
5.3 Alcohol addiction severity as Addiction Severity Index
alcohol score at six months
There was no significant difference between MII and MI for this
outcome (MD -0.02, 95% CI -0.07 to 0.03); one study, 163
participants (Korcha 2014); low-quality evidence), see Analysis
5.3.
5.4 Retention as number of people who completed all
treatment sessions (published and unpublished information)
There was no significant difference between MII and MI for this
outcome (RR 17.63, 95% CI 1.03 to 300.48; one study, 163
participants (Korcha 2014); low-quality evidence), see Analysis
5.4.
Secondary outcomes
5.5 Illicit drug abstinence as percentage of days
methamphetamine abstinent in the past six months (as
determined by timeline follow-back)
There was no significant difference between MII and MI for this
outcome (MD 3.91, 95% CI -5.28 to 13.10; One study, 163
participants (Korcha 2014); low-quality evidence), see Analysis
5.5.
5.6 Alcohol-related harms or problems
There were no data for this outcome.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Brief intervention (BI) compared to treatment as usual (TAU) to reduce alcohol consumption in PWID
Patient or population: concurrent problem alcohol and illicit drug users
Setting: opioid agonist treatment clinic, outpat ient clinic with/ without opioid agonist treatment, and primary care sett ing
Intervention: brief intervent ion (BI)
Comparison: t reatment as usual (TAU)
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with treatment as
usual (TAU)
Risk with Brief inter-
vention (BI)
Alcohol Use Disorders
Ident if icat ion Test (AU-
DIT) or Alcohol, Smok-
ing and Substance
Involvement Screening
Test (ASSIST) scores
Follow-up: 3 months
The mean alcohol Use
Disorders Ident if icat ion
Test (AUDIT) or Al-
cohol, Smoking and
Substance Involvement
Screening Test (AS-
SIST) score was 0
SMD 0.07 higher
(0.24 lower to 0.37
higher)4
- 170
(3 RCTs)
⊕⊕©©
LOW 12
Alcohol Use Disorders
Ident if icat ion Test (AU-
DIT) scores
Follow-up: 9 months
The mean alcohol Use
Disorders Ident if icat ion
Test (AUDIT) scores
was 11.6
MD 2.3 higher
(0.58 lower to 5.18
higher)
- 110
(1 RCT)
⊕⊕©©
LOW 13
Number of drinks per
week
Assessed with: unre-
ported
Follow-up: 3 months
The mean number of
drinks per week was 16.
3
MD 0.7 higher
(3.85 lower to 5.25
higher)
- 110
(1 RCT)
⊕⊕©©
LOW 13
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Number of drinks per
week
Assessed with: unre-
ported
Follow-up: 9 months
The mean number of
drinks per week at 9
months was 18.7
MD 0.3 lower
(4.79 lower to 4.19
higher)
- 110
(1 RCT)
⊕⊕©©
LOW 13
Decreased alcohol use
assessed with: 1st
quest ion f rom the Alco-
hol Use Disorders Iden-
t if icat ion Test: How of -
ten do you have a drink
containing alcohol?
Follow-up: 3 months
Study populat ion RR 1.13
(0.67 to 1.93)
110
(1 RCT)
⊕⊕©©
LOW 13
314 per 1,000 355 per 1,000
(210 to 605)
Decreased alcohol use
assessed with: 1st
quest ion f rom the Alco-
hol Use Disorders Iden-
t if icat ion Test: How of -
ten do you have a drink
containing alcohol?
Follow-up: 9 months
Study populat ion RR 1.09
(0.62 to 1.92)
110
(1 RCT)
⊕⊕©©
LOW 13
294 per 1,000 321 per 1,000
(182 to 565)
Retent ion
Assessed with: unpub-
lished and published
data
Follow-up: 3 months
Study populat ion RR 0.94
(0.78 to 1.13)
190
(3 RCTs)
⊕⊕©©
LOW 12
784 per 1,000 713 per 1,000
(611 to 831)
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: Conf idence interval; RR: Risk rat io; MD: mean dif ference;SMD: standardised mean dif ference; PWID: people who use illicit drugs
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GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Downgraded one level for risk of bias: high risk of detect ion bias (no blinding of outcome assessor, subject ive outcomes).
2 Downgraded one level for imprecision: only three studies with relat ively few part icipants included in comparison.
3 Downgraded one level for imprecision: only one study with relat ively few part icipants included in comparison.
4 The result corresponds to a small, stat ist ically insignif icant dif f erence.
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Motivational interviewing (M I) compared to treatment as usual (TAU) or educational intervention only to reduce alcohol consumption in PWID
Patient or population: concurrent problem alcohol and illicit drug users
Setting: opioid agonist clinics and outpat ient clinic with/ without opioid agonist treatment
Intervention: motivat ional interviewing (MI)
Comparison: t reatment as usual (TAU) or educat ional intervent ion only
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with treatment as
usual (TAU) or educa-
tional intervention only
Risk with Motivational
interviewing (M I)
Alcohol Use Disorders
Ident if icat ion Test (AU-
DIT) or Alcohol, Smok-
ing and Substance
Involvement Screening
Test (ASSIST) scores
Follow-up: 3 months
The mean alcohol Use
Disorders Ident if icat ion
Test (AUDIT) or Al-
cohol, Smoking and
Substance Involvement
Screening Test (AS-
SIST) scores was 0
SMD 0.04 higher
(-0.29 lower to 0.37
higher)4
- 141
(2 RCTs)
⊕⊕©©
LOW 12
Number of standard
drinks consumed per
day over the last 30
days
Assessed with: counts
Follow-up: 6 months
The mean number of
standard drinks con-
sumed per day over the
last 30 days was 3.9
MD 0.2 lower
(1.76 lower to 1.36
higher)
- 225
(1 RCT)
⊕⊕©©
LOW 23
Greater than 50%reduc-
t ion in number of stan-
dard drinks consumed
per day over the last 30
days
Assessed with: t imeline
follow back
Follow-up: 6 months
Study populat ion RR 1.01
(0.77 to 1.31)
256
(1 RCT)
⊕⊕©©
LOW 23
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494 per 1,000 499 per 1,000
(381 to 647)
Abst inence f rom alco-
hol over the last 30 days
Assessed with: t imeline
follow back
Follow-up: 6 months
Study populat ion RR 0.93
(0.57 to 1.50)
256
(1 RCT)
⊕⊕©©
LOW 23
230 per 1,000 214 per 1,000
(131 to 345)
Retent ion - end of treat-
ment
Assessed with: number
of people who com-
pleted all t reatment
sessions
Study populat ion RR 0.96
(0.87 to 1.06)
256
(1 RCT)
⊕⊕©©
LOW 23
885 per 1,000 850 per 1,000
(770 to 938)
Retent ion
Follow-up: 3 months
Study populat ion RR 0.93
(0.60 to 1.43)
160
(2 RCTs)
⊕⊕©©
LOW 23
738 per 1,000 671 per 1,000
(553 to 811)
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: Conf idence interval; RR: Risk rat io; MD: mean dif ference; PWID: people who use illicit drugs
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Downgraded one level for imprecision: only two studies with relat ively few part icipants included in comparison.
2 Downgraded one level for risk of bias: high risk of select ion and detect ion bias (subject ive outcomes).
3 Downgraded one level for imprecision: only one study with relat ively few part icipants included in comparison.26
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4 The result corresponds to a small, stat ist ically insignif icant dif f erence.
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Brief motivational interviewing (BMI) compared to assessment-only to reduce alcohol consumption in PWID
Patient or population: concurrent problem alcohol and illicit drug users
Setting: addict ion clinic
Intervention: brief motivat ional interviewing (BMI)
Comparison: assessment-only
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with assessment-
only
Risk with Brief mo-
tivational interviewing
(BMI)
Number of days with al-
cohol use
Assessed with: t imeline
follow back
Scale f rom: 0 to 31
Follow-up: 6 months
The mean number of
days with alcohol use
was 9.1 days
MD 1.5 days lower
(4.56 lower to 1.56
higher)
- 187
(1 RCT)
⊕⊕⊕©
MODERATE 1
25% reduct ion of drink-
ing days in the past 30
days
Assessed with: t imeline
follow back
Follow-up: 6 months
Study populat ion RR 1.23
(0.96 to 1.57)
187
(1 RCT)
⊕⊕⊕©
MODERATE 1
522 per 1,000 642 per 1,000
(501 to 819)
50% reduct ion of drink-
ing days in the past 30
days
Assessed with: t imeline
follow back
Follow-up: 6 months
Study populat ion RR 1.27
(0.96 to 1.68)
187
(1 RCT)
⊕⊕⊕©
MODERATE 1
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457 per 1,000 580 per 1,000
(438 to 767)
7 or more drinking days’
reduct ion in the past 30
days
Assessed with: t imeline
follow back
Follow-up: 6 months
Study populat ion RR 1.67
(1.08 to 2.60)
187
(1 RCT)
⊕⊕⊕©
MODERATE 1
239 per 1,000 399 per 1,000
(258 to 622)
Retent ion - end of treat-
ment
Assessed with: number
of people who com-
pleted all t reatment
sessions
Study populat ion RR 0.98
(0.94 to 1.02)
190
(1 RCT)
⊕⊕⊕©
MODERATE 1
968 per 1,000 949 per 1,000
(910 to 988)
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: Conf idence interval; RR: Risk rat io; MD: mean dif ference; PWID: people who use illicit drugs
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Downgraded one level for imprecision: only one study with relat ively few part icipants included in comparison.
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Motivational interviewing intensive (M II) compared to motivational interviewing (M I) to reduce alcohol consumption in PWID
Patient or population: concurrent problem alcohol and illicit drug users
Setting: an outpat ient substance use disorder treatment facility
Intervention: motivat ional interviewing intensive (MII)
Comparison: motivat ional interviewing (MI)
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with motivational
interviewing (M II)
Risk with Motivational
interviewing intensive
(M I)
Addict ion Severity In-
dex alcohol score
Assessed with: ASI
Follow-up: 2 months
The mean addict ion
Severity Index alcohol
score was 0.11
MD 0.03 higher
(0.02 lower to 0.08
higher)
- 163
(1 RCT)
⊕⊕©©
LOW 12
Addict ion Severity In-
dex alcohol score
Assessed with: ASI
Follow-up: 4 months
The mean addict ion
Severity Index alcohol
score was 0.16
MD 0.01 lower
(0.06 lower to 0.04
higher)
- 163
(1 RCT)
⊕⊕©©
LOW 12
Addict ion Severity In-
dex alcohol score
assessed with: ASI
Follow-up: 6 months
The mean addict ion
Severity Index alcohol
score was 0.16
MD 0.02 lower
(0.07 lower to 0.03
higher)
- 163
(1 RCT)
⊕⊕©©
LOW 12
Retent ion - end of treat-
ment
Assessed with: number
of people who com-
pleted all t reatment
sessions
Study populat ion RR 17.63
(1.03 to 300.48)
163
(1 RCT)
⊕⊕©©
LOW 12
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0 per 1,000 0 per 1,000
(0 to 0)
*The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: Conf idence interval; RR: Risk rat io; OR: Odds rat io; PWID: people who use illicit drugs
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Downgrared one level for risk of bias: high risk of detect ion bias (subject ive outcomes).
2 Downgraded one level for imprecision: only one study with relat ively few part icipants included in comparison.
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D I S C U S S I O N
Summary of main results
We included seven studies involving 825 participants in this re-
view. The studies assessed the effectiveness of eight psychoso-
cial interventions: cognitive-behavioural cognitive skills training
(CBCST), twelve-step facilitation (TSF) programme, brief in-
tervention (BI), motivational interviewing (MI) (group based),
MI (individual), educational hepatitis health promotion (HHP),
brief motivational interviewing (BMI), and intensive motivational
interviewing (MII). Comparing different psychosocial interven-
tions, we found three studies investigating BI versus treatment as
usual (TAU), and three studies investigating MI versus TAU (or
educational intervention only). We found only one study inves-
tigating each of the remaining interventions. None of the com-
parisons showed significant differences between the treatments in
terms of alcohol use, with the exception that participants receiving
BMI were significantly more likely to reduce their alcohol use by
seven or more days in the past 30 days at six months’ follow up
compared with participants receiving assessment-only.
Overall completeness and applicability of
evidence
The studies identified are insufficient to address all the objectives of
this review. All included studies were conducted either in theUSA,
Ireland or Switzerland, which limits their applicability to other
contexts. A substantial proportion of participants in the included
studies had significant problems with alcohol (e.g. a diagnosis of
abuse or dependence), which may have impacted on the effective-
ness of the short-term therapies and brief interventions offered to
them. These people may require more intensive interventions, as
BIs have been shown to be effective among people with less severe
alcohol problems (Raistrick 2006). Only two studies examined a
longer type of intervention (i.e. nine or 16 sessions); however, they
reported their outcomes in a way that precluded comparison with
other studies (Carroll 1998; Korcha 2014).
This review selected a very narrow clinical question that was lim-
ited to a very specific population. Although the size of this pop-
ulation is not negligible, it is highly unlikely that all of the indi-
viduals in a treatment service in a real-life setting will have both
of the conditions selected as the eligibility criteria for this review.
These stringent eligibility criteria strengthened the internal va-
lidity of the review; however, with an inevitable detriment to its
external validity. A typical clinician in an actual treatment clinic
would normally deal with a mixture of people who use illicit drugs
(PWID), who may or may not have other concurrent conditions
or comorbidities. To manage this demanding workload, they may
want to consider other studies, which did not meet the eligibility
criteria of our review.
Quality of the evidence
Key methodological limitations
Overall, we found mostly low-quality evidence for the compar-
isons and outcomes reported in this review. The methodological
quality of studies included in the review was variable. Most of
the studies did not describe the randomisation procedure and the
method to conceal allocation. All studies used only subjective out-
comes and 57% (four out of seven) were open-label. Risk of attri-
tion bias at the end of treatment was unclear or high in the 57%
of the studies (four out of seven) and low at follow-up (86%).
Indirectness of evidence
We did not include studies providing indirect evidence about our
research question in this review, for example trials that included
illicit drug users with and without concurrent problem alcohol
use. We did not identify other sources of indirectness, for example
interventions, outcomes or comparators.
Inconsistency of results
We identified only low levels of unexplained heterogeneity or in-
consistency in the results. Most studies did not find significant,
or found only small, differences in effectiveness between the com-
pared interventions on their primary outcomes.
Potential biases in the review process
There is a small chance that we missed some trials during the
identification of relevant studies. We did not limit our searches
to studies published in English; however, studies in non-English
languages may have been missed because they are commonly less
indexed in the selected databases. We may also have missed un-
published studies. Unpublished studies are likely to have negative
results, which can be a reason why they are not published. Owing
to the small number of included studies, we did not construct
a funnel plot to assess publication bias. The major limitation of
the review process was that most trials did not provide enough
published data, or did not provide data in a form that could be
extracted for meta-analysis. Although we emailed authors from
all responded and provided further data. Furthermore, we could
not include a number of potentially relevant studies, because they
involved PWID without problem alcohol use in their samples.
Agreements and disagreements with other
studies or reviews
Substantial evidence has described the value of psychosocial in-
terventions in treating problem alcohol use; however, it has re-
latedmostly to the general population, as noted above (EMCDDA
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2015). Furthermore, comparing the findings of our review with
those of other reviews is complicated by the fact that other studies
did not perform meta-analysis and we have minimal aggregated
results that would allow comparisons. As described in the back-
ground section, other narrative literature reviews have dealt with
our research population (Arias 2008; Bickel 1987). Similarly to
our work, these reviews were unable to identify evidence to answer
our question or to conduct a meta-analysis. Subsequently, they
based their conclusions on evidence from a mixed type of studies
(e.g. case studies, randomised controlled trials), or from studies
that included PWIDwithout concurrent problem alcohol use.We
excluded these type of studies from our review. Nevertheless, the
review by Arias and colleagues discussed 14 reports/studies about
the treatment of co-occurring alcohol and cocaine/opioid depen-
dence, two of which were included in our review (Arias 2008).
Two recent reviews examined alcohol consumption among people
pre- and post-treatment for other substance use disorders (Staiger
2013; Soyka 2015). They concluded that while concurrent alco-
hol is often highly prevalent in drug treatment, no clear patterns
have emerged and the literature remains inconclusive with respect
to toxicity for liver and effective interventions. Another recent re-
view questioned the evidence behind denial of treatment for al-
cohol use disorders and behind reduction of opioid agonist dose
in patients receiving opioid agonist treatment who test positive
on alcohol breathalysers (Nolan 2016). Online technologies show
promise in real-time assessment (handheld electronic diaries) and
treatment (smartphone apps and videos) of problem alcohol use
among concurrent PWID (Aharonovich 2017; Preston 2016).
This review is unintentionally entering the sensitive subject re-
garding the requirement of providing ancillary counselling ser-
vices to individuals in opioid agonist treatments. The questions
are whether counselling services provided to individuals receiv-
ing methadone maintenance treatment improve their outcomes,
and whether adding any psychosocial support to standard mainte-
nance treatments yields additional benefits. There are a number of
ways to answer these questions. While previous studies attempted
to answer these questions by providing evidence of the effective-
ness of psychosocial interventions (Amato 2011a; Gossop 2006;
McLellan 1993; Schwartz 2012), they have done so for general/
mixed conditions/outcomes, in studies in mixed populations with
or without concurrent alcohol problems, or involving mixed types
of interventions (i.e. pharmacological plus psychosocial). More-
over, it remains controversial to make these treatments mandatory
as the evidence for the effectiveness of compulsory treatment is
lacking (Werb 2016). In this review, however, we focused on a
single type of intervention and a ’pure’ population in which all
participants had both alcohol and drug problems. This may be
one of the reasons why our review found such a small number of
studies. A recent trial, which did not pose such restrictions, found
that if counselling was optional, and if counsellor was being re-
sponsible for enforcing clinic rules, there was no difference from
treatment as usual with methadone (Schwartz 2017). Neverthe-
less, our findings support the notion that the current evidence base
is too weak to answer this important question, as reported in a
previous Cochrane Review (Amato 2011a).
Another important question is what constitutes standard mainte-
nance/outpatient treatment. It appears that all standard treatments
contain some type of psychosocial support, which varies consid-
erably, and this makes it difficult to evaluate the added value of
additional services. This was apparent in studies included in our
review.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Based on the evidence we identified, which was mainly of low
quality, no reliable conclusions can be drawn regarding the effec-
tiveness of different types of psychosocial interventions to reduce
alcohol consumption in concurrent problem alcohol and illicit
drug users. Given the high rates of co-occurrence of problem alco-
hol use and other drug problems, the integration of alcohol- and
drug-orientated interventions appears a logical action; however,
the findings of this review are inconclusive.
Implications for research
This review emphasises the need for randomised controlled tri-
als (RCTs) to test the effectiveness of psychosocial interventions
in reducing problem alcohol use in people who use illicit drugs
(PWID). We recommend trials use robust methodology and are
well reported to allow for critical appraisal. For researchers plan-
ning an RCT in this area, we recommend that they design their
study considering the following (according to the EPICOT format
for research recommendations on the effects of treatments; Brown
2006).
• Evidence (what is the current state of the evidence?): the
current evidence is limited to seven RCTs conducted in an
outpatient/community setting, three of them with an
accompanying opioid agonist treatment. More RCTs are needed.
• Population (what is the population of interest?): adults,
including younger adults, who are identified as PWID with
concurrent and confirmed problem alcohol use; people in or out
of formal addiction treatment.
• Intervention (what are the interventions of interest?):
psychosocial interventions (e.g. motivational interviewing (MI),
cognitive-behavioural therapy (CBT), contingency management,
family therapy, brief intervention (BI), etc.).
• Comparison (what are the comparisons of interest?):
treatment as usual, no intervention, waiting list, other
psychosocial interventions; pharmacological treatments (alone,
33Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users (Review)
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or in combination with psychosocial treatments); interventions
of different type, length and intensity.
• Outcome (what are the outcomes of interest?): reduction
in/abstinence from alcohol or drug use, or from both. In order to
be able to combine the outcomes of future trials with our current
data, outcome measures of future trials should include formal
validated instruments, for example the AUDIT questionnaire or
other core set of outcomes that researchers agree on and apply
(see COMET initiative). Objective measures of these outcomes
should be used in conjunction with self-reports wherever
possible (for example, breathalysers, urinalysis).
• Time stamp (date of literature search): for this review,
searches were conducted on 22 November 2011, then updated in
June 2014 and August 2017.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Carroll 1998
Methods Study design: RCT, single blind.
Recruitment modality of participants: individuals seeking treatment at the outpatient
treatment unit of the APT Foundation, or respondents to newspaper advertisements or
public service announcements
Participants Number of participants: 122 (41 in 2 arms selected for this review).
Gender: 27% female.
Mean age: 30.8 years (SD 5.5 years).
Condition: ”All subjects met current DSM-III-R criteria for cocaine dependence, and
for concurrent alcohol dependence (85%) or alcohol abuse (15%)“
Other relevant information:
(1) TSF arm - baseline substance use:
• mean weekly cocaine use 5.4 ± 8.6;
• days cocaine use/past 30 days 12.7 ± 8.0;
• cocaine use g/week/past 30 days 4.6 ± 6.6;
• mean drinks per drinking day/past 30 days 10.2 ± 5.7;
• days of alcohol use/past 30 days 12.3 ± 8.0;
• years of cocaine use - lifetime 7.5 ± 3.9;
• years of alcohol misuse - lifetime 7.1 ± 6.3;
• lifetime psychiatric disorders: any affective disorder 24%, any anxiety disorder
24%, ASP 42%, any non-ASP 35%;
• ASI composite scores: medical 0.15 ± 0.26, employment 0.71 ± 0.28, legal 0.09 ±
0.18, family/social 0.21 ± 0.15, psychological 0.26 ± 0.17, alcohol 0.30 ± 0.19, cocaine
0.58 ± 0.24, other drugs 0.06 ± 0.06;
• race: white 40%, African-American 56%, Hispanic 0%, other 4%;
• married/cohabiting 42%;
• unemployed 76%;
• education: less than high school 40%;
• primary route of administration: nasal 20%, smoking 72%, intravenous 8%;
• previous treatment: alcohol 36%, drugs 72%.
(2) CBCST arm - baseline substance use:
• mean weekly cocaine use (mean ± SD) 5.6 ± 6.2;
• days cocaine use/past 30 days; 15.6 ± 6.5;
• cocaine use g/week/past 30 days 5.0 ± 5.1;
• mean drinks per drinking day/past 30 days 10.6 ± 8.0;
• days of alcohol use/past 30 days 18.5 ± 7.6;
• years of cocaine use - lifetime 5.8 ± 3.1;
• years of alcohol misuse - lifetime 7.3 ± 6.4;
• lifetime psychiatric disorders: any affective disorder 33%, any anxiety disorder
6%, ASP 46%, any non-ASP 50%;
• ASI composite scores: medical 0.19 ± 0.29, employment 0.67 ± 0.32, legal 0.09 ±
0.17, family/social 0.12 ± 0.15, psychological 0.16 ± 0.19, alcohol 0.40 ± 0.20, cocaine
0.58 ± 0.18, other drugs 0.07 ± 0.05;
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Carroll 1998 (Continued)
• race: white 32%, African-American 63%, Hispanic 1%, other 0%;
• married/cohabiting 32%;
• unemployed 53%;
• education: less than high school 32%;
• primary route of administration: nasal 11%, smoking 84%, intravenous 5%;
• previous treatment: alcohol 32%, drugs 58%.
Interventions The trial included 5 treatment arms: CBCST plus disulphiram; TSF plus disulphiram;
CM plus disulphiram; CBCST plus no medication; TSF plus no medication
We considered the 2 non-medication psychotherapy arms only:
(1) CBCST was based on Marlatt 1996’s relapse prevention model;
(2) TSFwas adapted from that used in ProjectMATCHandwas grounded in the concept
of substance use disorder as a spiritual and medical disease
Route of delivery: treatments were manual-guided; 4 doctoral-level psychologists con-
ducted CBCST; 2 masters-level clinicians conducted TSF
Number of participants allocated to each group: 25 in CBCST plus no medication;
19 in TSF plus no medication (data provided for 24 and 18 participants, respectively)
Duration of the intervention: 16 individual sessions, twice weekly over 12 weeks.
Duration of follow-up: 12 weekly assessments within-treatment, and at 1, 3, 6, 12
months
Country of origin, setting: a non-profit substance use treatment centre - APT founda-
tion (https://aptfoundation.org/) - affiliated with Yale University in New Haven, Con-
necticut, USA
Outcomes • Alcohol abstinence as maximum number of weeks of consecutive alcohol
abstinence during treatment
• Illicit drug abstinence as maximum number of weeks of consecutive abstinence
from cocaine during treatment
• Alcohol abstinence as number achieving 3 or more weeks of consecutive alcohol
abstinence during treatment
• Illicit drug abstinence as number achieving 3 or more weeks of consecutive
abstinence from cocaine during treatment
• Alcohol abstinence during follow-up year
• Illicit drug abstinence as abstinence from cocaine during follow-up year
• Retention - end of treatment (unpublished)
Notes All sessions were recorded and checked and rated for accuracy and fidelity of the inter-
vention
”Subjects also met weekly with an independent clinical evaluator who collected urine
specimens, assessed cocaine and alcohol use and monitored other clinical symptoms.“
”Patients were paid $25 for each follow-up interview, with a $10 increase for each
consecutive interview they attended, to encourage more complete data collection. In
addition, patients were paid a $5 bonus for attending an interview within 28 days of the
target interview date.“
• Only 39 participants completed the full 12-week treatment (compliant treatment
completers).
• Participants in the pharmacological arms stayed longer in treatment (participants
were not blind to their intervention), although the difference between the two
psychotherapy arms included in the present review was not significant (70% versus
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Carroll 1998 (Continued)
78%), see Analysis 1.4.
• The specific type of self-report questionnaires was not reported in the primary
paper (1998), only in the follow-up paper.
• Results are reported as number of weeks of continuous abstinence.
• The follow-up report (2000) does not provide any endpoint scores (only results of
the random-effects regression model).
• Use of cocaine and alcohol was strongly associated with each other during
treatment, particularly for the subjects assigned to disulphiram.
• The study was funded by National Institutes of Health; information on conflicts
of interest was not provided.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not enough informationprovided; e.g. ”Of
the 122 randomised subjects, 117 initiated
the treatment“
Allocation concealment (selection bias) Unclear risk Not stated.
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Low risk Within-study assessments:
”independent clinical evaluator who col-
lected urine specimens, assessed cocaine
and alcohol use; the evaluator saw patients
in an office physically separated from the
therapy offices and instructed patients not
to disclose detail of their therapist or treat-
ment“.
Follow-up assessments (2000 paper):
”Patients were assessed at face-to-face fol-
low-up interviews conducted 1, 3, 6 and
12 months after the 12-week termination
point by an independent clinical evaluator
who was blind to both psychotherapy and
pharmacotherapy condition“
Incomplete outcome data (attrition bias)
End of Study outcomes
High risk Within-treatment assessments (1998):
”Assignment to disulphiram was associated
with significantly better retention in treat-
ment“
The psychotherapy groups had signifi-
cantly lower retention rates than the med-
ication groups:
”subjects assigned to disulphiram treat-
ment were retained significantly longer
than those assigned to no medication (8.4
versus 5.8 weeks. F= 8.7, p< 0.05)“
Retention rates:
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Carroll 1998 (Continued)
• CBT/disulphiram group (mean 8.8
weeks);
• CM/disulphiram (8.4 weeks);
• TSF/disulphiram (8.0);
• CBT/no medication (6.3);
• TSF/no medication (5.3).
”However, such analyses, ..., are con-
founded by differences among the treat-
ments in retention“
Only 30% completed treatment, however:
”Subjects who remained in treatment the
full 12 weeks/16 sessions (n=39) did not
differ from those who did not start treat-
ment or dropped out (n=83) in terms of
gender, race, employment status, route of
administration, presence of lifetime affec-
tive, anxiety or antisocial personality dis-
order, but those who met criteria for a
nonASP Axis II disorder, were significantly
more likely to complete treatment than
these who did not (48.1% versus 23.1%)“
Comments:
1) baseline characteristics provided for the
ITT sample (n = 122); but
2) rates of consecutive abstinence provided
for the exposed sample (n = 117);
3) it is not known whether missing out-
come data were balanced in numbers across
intervention groups, because group break-
downs for drop-outs are not provided;
4) psychotherapy groups (CBT, TSF) dif-
fered significantly at baseline: for frequency
of alcohol use; and medication groups had
lower baseline cocaine use
Incomplete outcome data (attrition bias)
Follow up
High risk All groups had a comparable number of
follow-up data points.However, number of
drop-outs was not reported for each group
separately
”It is possible that poorer-functioning sub-
jects who dropped out of treatment early
were under-represented in the follow-up
data, inflating outcomes in all groups“
”Participants who completedmore sessions
had better outcomes during follow-up“
• Subjects with higher age of onset of
drug use had more follow-up data
• Subjects with non-ASP Axis II
disorders had more follow-up data
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Carroll 1998 (Continued)
• No significant differences between
those followed up and those not followed
up
Percentage of treatment days abstinent
from cocaine, percentage of treatment days
abstinent from alcohol, percentage of co-
caine-negative urine screens, medication
compliance during treatment
Number of dropouts and reasons:
Number randomised: 122 (25 TSF, 19
CBT)
Number initiated: 117 (23 TSF, 18 CBT)
- no other reason provided
Number removed from the trial: 8 (1 did
not comply with medication, 1 medication
side effects. 4 clinical deterioration, 2 ad-
ministrative discharge)
Number drop-outs: 70 (no group break-
downs - no other reasons)
Number completed treatment: 39
Number followed up at least once: 96, i.e.:
• 1 month: 68;
• 3 months: 67;
• 6 months: 63;
• 12 months: 72.
Selective reporting (reporting bias) Low risk
Darker 2016
Methods Study design: cluster-RCT (”Pilot cluster randomized controlled trial feasibility study“)
Recruitment modality of participants: four addiction clinics in Dublin, Ireland
Participants Number of participants: 465
• Of the total 465 trial participants, we included a subgroup of 50 participants for
whom alcohol was the target substance (i.e. those who received a BI for alcohol in the
intervention group), or who were eligible to receive an intervention for alcohol based
on their ASSIST score in the control group (but received TAU).
• After accounting for the cluster-RCT design effect, the effective size of the
included sample was n = 31.
Gender: 64.5% male (300/465)
Mean age: 37 years
Condition: participants with opioid use disorder receiving methadone who also had
concurrent problem alcohol use, as determined by positive ASSIST-alcohol score
Other relevant information:no significant differences between intervention and control
group for: gender, age, age leaving school, age at first druguse, length of current treatment,
global risk score at baseline
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Darker 2016 (Continued)
Interventions (1) Brief Intervention (BI) n = 13
(2) Treatment as usual (TAU) n = 18
Clinical staff were trained in the use of the Alcohol, Smoking and Substance Involvement
Screening Test (ASSIST) questionnaire
Clinical staff in the intervention sites were also trained in the delivery of brief interven-
tions (BIs) using the modified BI manual
All patients received an ASSIST screening, and patients in the intervention clinics who
were identified as moderate or high risk for a particular substance received a BI by staff
immediately after screening
High-risk patients were also referred for further follow-up and counselling with the in-
house counselling team (n = 196)
Patients in the control clinics received treatment as usual (TAU) (n = 269)
Outcomes • The primary outcome measure was the change in ASSIST score from baseline to
3-month follow-up.
• Substance use global risk score (except smoking)
• Retention - at three months
• The secondary outcome was feasibility of administering a BI within daily practice,
as assessed by intervention fidelity checks, patient satisfaction questionnaires and
process evaluation clinician focus groups.
• For the purposes of this review, the study authors provided unpublished data for
ASSIST-alcohol at baseline and 3 months.
• The data used in this review include only those participants for whom alcohol was
the target substance, i.e. those who received an intervention for alcohol in the
intervention group, or whom were eligible to receive an intervention for alcohol based
on their ASSIST score in the control group (but received treatment as usual).
Notes • Patients with high-risk ASSIST scores also received a referral to further follow-up
and counselling with the in-house counselling team.
• Further clinician training in administering the ASSIST questionnaire and BI was
delivered “where necessary” with top-up sessions, but it is not clear which treatment
group was affected. Furthermore, ongoing fidelity of BI treatment was assessed over the
course of the study, and feedback was provided to the clinicians.
• Unpublished quote: ”In our study we screened participants for a range of
substances (e.g. alcohol, cannabis, cocaine, opioids) and only intervened on the
substance that received the highest score based on the ASSIST. We screened for tobacco
use but due to the population it was decided not to intervene for tobacco. If tobacco
was the target substance clinicians were instructed in administer the intervention for
the second highest scoring substance.“
• Unpublished quote: ”Our study was not powered to detect changes in individual
substances. Our reported results are based on participants global risk scores. However,
we can see from the means depicted in the table above that there appears to be a trend
for a greater reduction in alcohol ASSIST scores in the intervention groups as opposed
to the control group. There is a reduction in the control group that was determined to
be as a result of the Hawthorn effect.“
• Selection of clinics is not explicitly described but is assumed to be based on
convenience.
• The study was funded by Health Research Board Ireland; no conflicts of interest
were reported.
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Darker 2016 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Personal communication: “randomization
was conducted by a third party bio-statis-
tician.”
Allocation concealment (selection bias) Unclear risk Not reported.
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Unclear risk Blindness of participants and personnel not
possible for the kind of intervention. Blind-
ness of outcome assessor not specified
Incomplete outcome data (attrition bias)
End of Study outcomes
Low risk Information on dropout from the study
provided; missing outcome data were bal-
anced in numbers across intervention
groups, with similar reasons for missing
data across groups
Incomplete outcome data (attrition bias)
Follow up
Low risk Missing data have been imputed using ap-
propriate methods.
Comment: although the primary outcome
measure was a change in ASSIST score, the
paper doesn’t present this in any graph, but
instead mentions the difference in ASSIST
scores at 3m in a single paragraph (p.1109
- did the intervention work?). It’s not clear
whether this is the total score or the change
in score. Also, the published graphs focus
on key predictors of higher ASSIST scores,
which was not part of the projected out-
come measure
• At 3 months, in the ASSIST-alcohol
positive subgroup, 13 participants (100%)
were retained in the intervention arm, and
18 participants (100%) in the control arm
(unpublished data);
• At 3 months in the total sample,
92% (181/196) intervention, 76% (204/
269) control (published data)
Selective reporting (reporting bias) Low risk
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Feldman 2013
Methods Study design: RCT.
Recruitment modality of participants: for 1 year, participation in the study was pro-
posed systematically to each adult outpatient who was treated for opioid or cocaine use
disorder
Participants Number of participants: 110
Gender: 72.3% male
Mean age (mean ± SD): 35 ± 7.8 years
Condition: problem alcohol use based on questions from the AUDIT questionnaire, i.
e. excessive drinking (7 ≤ AUDIT score < 13 for men and 6 ≤ AUDIT score < 13 for
women); and alcohol use disorder (score > 13)
43.8% were classified as having excessive drinking and 56.2% as having alcohol use
disorder
Other relevant information
Opioid use disorder treatment with methadone (56.2%) or diacetyl morphine (12%);
No opioid agonist and treatment for opioid or cocaine use disorder (31.7%).
Most participants with opioid or cocaine use disorder also had tobacco or cannabis use
disorder
Most participants had 1 or more concomitant psychiatric disorders (mood disorder, 35.
6%; personality disorder, 34%; anxiety disorders, 14.7%; psychotic disorders, 9.4%)
”Diagnoses were established according to the criteria of the ICD-10 by a resident and a
senior psychiatrist“
Interventions (1) BI (n = 60)
BI was delivered in 1 session, based on WHO guidelines, delivered by trained staff
(4 hours’ training). The intervention group received the same TAU as controls. The
outpatient staff consisted of a psychiatrist, general practitioner, psychologist, nurse, and
social worker
(2) TAU (n = 52)
”The control group received TAU in addition to AUDIT and score feedback. TAU refers
to outpatient pharmacological and psychosocial treatment. Maintenance treatment with
methadone or heroin included medical and psychiatric follow-up, primary health care,
psychosocial interventions, and administration of opiate treatments in a clinical setting.
Psychosocial treatment included medical and psychiatric follow-up, primary health care,
psychosocial interventions, and, if necessary, administration of pharmacotherapy in a
clinical setting.“
Duration of the intervention: (mean ± SD): 16 ± 4.7 minutes
Duration of follow-up: 3 and 9 months
Country of origin, setting: specialised outpatient clinic in the Division of Substance
Abuse of the University Hospitals of Geneva, Switzerland
Outcomes • Alcohol use as AUDIT scores at 3 months
• Alcohol use as AUDIT scores at 9 months
• Alcohol use as number of drinks per week at 3 months (number of glasses of
alcohol per week, 1 glass: 10 g of alcohol; wine = 100 mL; beer = 250 mL; spirits = 25
mL)
• Alcohol use as number of drinks per week at 9 months
• Alcohol use as decreased alcohol use at 3 months
• Alcohol use as decreased alcohol use at 9 months
• Increased or unchanged alcohol use at 3 and 9 months (i.e. reverse of the above)
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Feldman 2013 (Continued)
• Retention - at 3 months
Notes The participants in both groups were already in treatment for opioid or cocaine depen-
dence before study inclusion. Participants allocated to BI received this intervention 2 or
3 weeks after AUDIT screening
The WHOManual recommends the referral of individuals with alcohol dependence to
specialist treatment without providing BI
All screened participants received feedback that explained the meaning of their AUDIT
score
The study funding source was not reported; no conflicts of interest were reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: ”The randomisation scheme was
drawn by a statistician, who used the Web
site [http://www.randomizer.org/]. A ran-
dom permuted block method was used,
with blocks of 4 patients“
Allocation concealment (selection bias) Low risk Quote: ”The sequence was concealed from
all investigators with numbered opaque
sealed envelopes prepared by the statistician
and handed over to the physician in charge
of the study“
Blinding of outcome assessment (detection
bias)
Subjective outcomes
High risk Not stated.
Unpublished information: ”There is no
blinding assessment“.
Incomplete outcome data (attrition bias)
End of Study outcomes
Unclear risk Not available. The study did not assess out-
comes at the time of the study end
Incomplete outcome data (attrition bias)
Follow up
Low risk Modified ITT analysis (multiple imputa-
tion, random assumption).
At T0 - 1 person not included in analysis
because of data-entry errors, both in both
control and intervention group
Number of dropouts and reasons:
”Of the BI group, 59.3% completed the
last observation and of the control group,
58.8% completed it“
• Intervention (T0 = 51, T3 = 29, T9
= 30)
• Control (T0 = 59, T3 = 30, T9 = 35)
No reasons provided for dropouts, but re-
gression showed no differences: ”logistic re-
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Feldman 2013 (Continued)
gressions showed that the - Type of drinker
- and - Treatment group - did not explain
the missingness of data“.
”Hence, these variables displayednopartic-
ular pattern, meaning that the data for ex-
cessive drinkers and for alcohol-dependent
patients, as well as for the control group
and the intervention group, were equally
likely to be missing“
Comment: dichotomous outcomes: 40%
of participants dropped out, but the pro-
portion of missing outcomes compared
with the observed event risk (for all out-
comes except retention in treatment or
drop out), which was 10%-20% (control)
, and 60%-80% (intervention), was not
enough to have a clinically relevant impact
on the intervention effect estimate
Selective reporting (reporting bias) Low risk
Henihan 2016
Methods Study design: cluster-RCT.
Recruitment modality of participants: 16 general practitioners selected by random
stratified sampling (by location and level ofmethadone provision training), each recruited
10 consecutive patients receiving addiction care, including methadone
Participants Number of participants: 81 participants were included in the trial (34 in the interven-
tion group, 47 in the control group). Only participants with positive AUDIT at baseline
(n = 30) were included in this systematic review
Gender: 61.7% male
Mean age (mean ± SD): 42 ± 8.5 years
Condition: participants were > 18 years old, receiving primary care addiction treatment
including methadone (80/81 patients). For the purpose of this review, only patients who
were AUDIT-positive at baseline were included. The threshold for positive scores was 8
or more points
Other relevant information
Participants were excluded if they were age < 18 years, acutely intoxicated, cognitively
impaired including severe mental illness, or had language difficulties
Interventions (1) BI (n = 13):
Physicians randomised to the intervention group screened participants using the AU-
DIT-C and provided a brief intervention to patients who were positive for ’hazardous’
or ’harmful’ alcohol use
Delivery of the intervention was confirmed by interviews with physicians, patients, and
chart reviews
Cointeventions: GPs received a complex intervention to promote screening and brief
intervention which included practice visits, best practice guidelines and education, mul-
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Henihan 2016 (Continued)
timedia educational tools, MI-related training presentations, and demonstration of in-
terventions
(2) TAU (n = 17):
Physicians randomised to the control group were given training at the end of the trial (3
months)
Duration of follow-up: 3 months
Country of origin, setting: 16 general practices in Ireland (Health Service Executive
Mid-West and Dublin Mid-Leinster regions)
Outcomes • Alcohol use as AUDIT scores at 3 months
• Retention at 3 months
• Feasibility of the study was assessed by physician and patient retention.
• Acceptability of the intervention was assessed by a physician Short Alcohol and
Alcohol Problems Perception Questionnaire, as well as by qualitative interviews of both
physicians and patients.
• Efficacy among patients was assessed by an AUDIT-C and AUDIT assessment at
baseline and 3 months, as well as rates of patients self-reporting screening, brief
interventions and referral to treatment at 3 months after intervention.
Notes The BI was part of a complex implementation strategy to increase the uptake of BIs
by general practitioners. Actual delivery of the intervention by GPs and fidelity of the
intervention were not tested
The study was funded by Health Research Board Ireland; no conflicts of interest were
reported
The trial analysis calculated an intra cluster correlation coefficient (ICC) for care process
and outcome measures. The ICC for the proportion of patients with positive AUDIT-
C (follow up) results was 0.11 (standard error [SE] = 0.013). The ICCs for screening,
BI and referral to treatment were 0.016 (SE 0.014), -0.06 (SE 0.017), and 0.22 (SE 0.
026), respectively
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Personal communication: “external statis-
tician”.
Allocation concealment (selection bias) Low risk ”External statistician emailed anonymous
sequence of numbers to researcher who
matched themwith the unique study iden-
tifiers of participants.”
Blinding of outcome assessment (detection
bias)
Subjective outcomes
High risk Blinding of participants and personnel not
possible for the kind of intervention
“Outcome assessors not blinded.”
Incomplete outcome data (attrition bias)
End of Study outcomes
Low risk “Baseline: 1 GP dropped out.”
Random allocation: “dropouts: two inter-
vention GP practices and 11 patients from
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Henihan 2016 (Continued)
these practices.”
Incomplete outcome data (attrition bias)
Follow up
Low risk Follow up: “14 patient dropouts (interven-
tion (n=7) and Control (n=7))”
information on drop out from the study
provided; Missing outcome data balanced
in numbers across intervention groups,
with no reasons for missing data provided;
Selective reporting (reporting bias) Low risk
Korcha 2014
Methods Study design: RCT - open label
Recruitment modality of participants: an outpatient substance use treatment facility
in Northern California and by local advertisements
Participants Number of participants: 163 participants with methamphetamine (MA) use disorder
were randomly assigned to Intensive MI or a StandardMI intervention with an attention
control activity to achieve time equivalence for the Intensive MI intervention
Gender: 53.3% female
Mean age: 37.8 years
Condition: diagnosis of both methamphetamine use disorder and 1+ criterion of alcohol
abuse/dependence (DSM-IV criteria) within previous 12 months
Other relevant information
• Among this sample of participants with MA use disorder, a majority (75%) also
reported some level of problems with alcohol.
• The included paper examined outcomes for alcohol problem severity among men
and women in both study conditions.
• Caucassian: 68.5% (experimental), 66.3% (control).
Interventions (1) Intensive motivational interviewing (n = 80):
• an intensive 9-session version of motivational interviewing (MII) was compared
to a standard, single MI session.
• 9 x 50 mins, group 3 x week
• 3/9 of presentation slides taken from NIDA CTN manuals;
(2) Standard motivational interviewing + nutrition education (n = 83):
• attention control active
• 1 x 90 min of standard MI + 8 nutrition classes x 60 mins each.
Outcomes • Alcohol use at 2-, 4- and 6-month follow-up as measured by Addiction Severity
Index- Lite (ASI).
• Methamphetamine use (PDA % days abstinent, TLFB).
• The number of days of non-use between study entry and the 6-month follow-up
interview were summed and divided by the total number of days to obtain a percentage
of days of abstinent (PDA).
• Therapeutic alliance as measured by Helping alliance questionnaire.
• Retention - end of treatment (unpublished)
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Notes Both groups received outpatient CBT on craving 3x/week for up to 12 weeks (Galloway
2000; Stalcup 2006; Galloway 2007).
Participants also received weekly research interviews, Helping Alliance Questionnaires
(HAQ) and Timeline Follow-Back (TLFB) assessments of CM use - all assessment/
interventions that could potentially influence outcomes
We are unsure whether alcohol was covered in the nutrition class (control intervention)
Retention in control arm (comprised of a single MI session + 8 nutrition classes):
• none (zero) completed all 9 control arm sessions;
• 8 controls completed 8 control arm sessions.
While participants with “serious” psychiatric diagnoses were excluded from the study,
those with “psychiatric conditions that could be managed on an outpatient basis” were
referred to mental health services while they were in the study
Nine (5.5%) participants were legally mandated to treatment.
The study was funded by National Institutes of Health; information on conflicts of
interest was not provided
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Participants were assigned to a
condition using stratified permuted blocks
to ensure that gender andMA severity were
balanced in both conditions.”
Personal com-
munication: participants were assigned to
a study condition based on stratified ran-
domisation procedures that ensured gender
and MA severity were approximately equal
in both conditions (four strata). MA sever-
ity was determined by past 30 day use at
the baseline interview, per timeline follow-
back, operationalised as 10 or more days of
use of methamphetamine vs. less than 10
days of use
Allocation concealment (selection bias) Low risk Personal communication: opaque ran-
domisation envelopes were prepared in ad-
vance and not opened until immediately
prior to the initial individual MI therapy
session
Blinding of outcome assessment (detection
bias)
Subjective outcomes
High risk Personal communication: no blinding.
Incomplete outcome data (attrition bias)
End of Study outcomes
Low risk Quote: “Follow-up rates were excellent,
with over 90% completing interviews at
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each follow-up time point.”
Incomplete outcome data (attrition bias)
Follow up
Low risk Personal communication: “longitudinal
analysis using maximum likelihood meth-
ods allowed for inclusion of all study par-
ticipants, regardless of whether they were
interviewed at each time point or not. Ad-
ditionally, over 90% completed 2- and 6-
month interviews with over 87% complet-
ing all interviews.”
Selective reporting (reporting bias) Low risk
Nyamathi 2010
Methods Study design: RCT open label, 3 arms.
Recruitment modality of participants: flyers displayed in 5 methadone treatment sites.
Participants Number of participants: 256
Gender: 59.2% male
Mean age (mean ± SD): 51.2 ± 8.4 years
Condition: reported moderate-to-heavy alcohol use based on questions from the ASI.
Methadone maintenance treatment was an inclusion criterion (minimum 3 months)
Other relevant information:
• Fair/poor health: 60.4%
• Depressive symptoms: 80.8%
• Poor emotional well-being: 67.5%
• Ethnicity: African-American: 45.1%; white: 18.8, Latino: 26.7, Other: 9.4.
Education: high school graduate 58%
• Partnered: 54.3%
• Employed: 17.3%
• Recent alcohol use at baseline (mean number standard drinks last 30 days): 0-40:
25.1; 41-89: 24.7; 90-180: 26.7; 180+: 23.5
• Marijuana use in past 30 days: 16%
• IDU in past 30 days: 40%
• Smoke > 1 pack/day: 56.1%
• Self-help programme in past 30 days: 21.2%
• Social support: a) primarily from drug users 12.6%; b) primarily non-drug users
48.6%, c) both: 34.9%
Interventions (1) HHP: didactic style, also interactive as the group raised questions. Delivered by a
nurse and hepatitis-trained research assistant. Sessions based on “The comprehensive
health seeking and coping paradigm (CHSCP; Nyamathi 1989), originally adapted from
Lazarus and Folkman’s (1984) stress and coping paradigm and Schlotfeldt’s (1981) health
seeking paradigm.” Staff trained on the integration of the CHSCP into their education
delivery
Focus: progression of HCV infection and the culturally sensitive strategies that infected
individuals can adopt to prevent or reduce accumulated damage to liver functioning.
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Strategies included: discussing the dangers of alcohol use on hepatitis (cognitive factors)
, discussing ways to avoid alcohol and other drugs, eating a balanced diet, dangers of
reinfection of HCV by IDU, receiving unsafe tattoos and piercing, having unprotected
sexual behaviour, and being consistent in engaging in other health-related behaviours.
Additional health promoting activities: enhancing coping, such as seeking positive social
support, getting support from religion and building self-esteem in individuals with a
history of drug and alcohol addiction. The HHP was directed by a detailed protocol (n
= 87)
(2) MI-group: focus: alcohol, risky behaviours, MI spirit; by trained MI specialists, i.e. a
PhD-prepared psychologist conducted primarily the MI-group sessions. Content of the
individual and group sessions was identical, guided by a detailed protocol and biweekly
meetings with the investigator and therapists. The average number of participants was
6 (range 5 to 7) (n = 79)
(3) MI-single: focus: alcohol, risky behaviours, MI spirit; a MSW-prepared researcher
conducted primarily the individual MI sessions (n = 90)
Duration of the interventions: 3 x 60-minute sessions, spaced 2 weeks apart
Duration of follow-up: 6 months.
Country of origin, setting: 5methadone treatment sites in Los Angeles and SantaMonica,
USA
Outcomes • Alcohol use (unpublished) as number of standard drinks consumed per day over
the last 30 days
• Illicit drug use (unpublished) as frequency of drug use (as measured by ASI drug)
• Illicit drug use (unpublished) as a composite drug score (frequency*severity for all
drugs taken)
• Alcohol use as > 50% reduction in number of standard drinks consumed per day
over the last 30 days
• Alcohol abstinence as abstinence from alcohol over the last 30 days
• Retention - end of treatment
Notes 6 participants reported no alcohol use at baseline.
A total of 86.7% of participants completed all 3 sessions and 91.3% completed the 6-
month follow up
The sessions were open; i.e. participants who had not completed their 3 sessions with
their original cohort could complete with a later cohort
The original protocol describes HHP as a control intervention (UCG)
Means (SD) of outcomesmeasures (ASI, TLFB) are not provided for any of the outcomes;
baseline scores are also not provided
The study was funded by National Institutes of Health; no conflicts of interest were
reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “This study was a randomised con-
trolled trial”
Unpublished information: “As participants
were enrolled, they were systematically as-
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signed to each of the three arms. In terms
of randomisation, we used random assign-
ment using a random number table”
Allocation concealment (selection bias) Unclear risk Information not reported.
Blinding of outcome assessment (detection
bias)
Subjective outcomes
High risk Masking: open label.
Source of information: published protocol
of the trial.
Incomplete outcome data (attrition bias)
End of Study outcomes
Unclear risk Not available. The study did not assess out-
comes at the time of the study end
Incomplete outcome data (attrition bias)
Follow up
Low risk Comment:
All analyses were ITT; however, it is not
stated which method of data imputation
was used for ITT analysis.
Missing data balanced across groups.
Comparability of all 3 arms assessed at base-
line.
Number of dropouts and reasons:
• MI-S (90), 86% completed all
sessions, 9% lost to follow up;
• MI-G (79), 85% completed all
sessions, 10% lost to follow up;
• HHP (87), 89% completed all
sessions, 7% lost to follow up.
Unpublished information: “The 6 reported
abstainers were distributed as follows: 2 in
MI-Single, 3 in MI-Group and 1 in HHP.
No one was excluded from the final regres-
sion model based on ethnicity. The state-
ment was erroneously carried over from
preliminarymodelling.However, since eth-
nicity was not important in that modelling,
it was not included in the final model and
there was no need to exclude anyone based
on ethnicity.
The 6 abstainers were excluded from the lo-
gistic regression analysis. ”A missing value
for drug-using partners caused an addi-
tional case to be omitted (actually there
were 248 cases in the regression model
rather than 249. Two subjects had missing
values for drug-using partners)“
Selective reporting (reporting bias) Low risk
56Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Stein 2002
Methods Study design: RCT.
Recruitment modality of participants: study was advertised at 3 NEP sites using
posters. NEP volunteers offered all clients referral cards. NEP clients called a study tele-
phone to be screened by a research assistant at a separate research site in hospital. During
the initial study visit, all NEP clients presented their study cards (received at NEP).
Conducted between February 1998 - October 1999
Participants Number of participants: 187
Gender: 119 male (63.6%)
Mean age: 36.2 years
Condition: problem alcohol use, i.e. AUDIT-positive (> 8) active IDUs. ”Current al-
cohol abuse or dependence diagnosis was ascertained using the SCID interview. 159
(85.0%) met DSM-IV criteria for current alcohol abuse (80%) or dependence (70%)
“. Participants were eligible if they were not receiving formal drug or alcohol treatment,
with the exception of self-help groups
Other relevant information
Baseline sample characteristics:
• mean number of years of education: 11.5 years;
• ethnicity: 162 (86.6%) Caucasian;
• most frequently injected drug: heroin for 141 (75.4%) participants, cocaine for
15 (8.0%), heroin and cocaine for 31 (16.6%);
• 120 (64.1%) participants visited the NEP at least once a month;
• mean AUDIT score at screening was 22.2;
• 159 (85.0%) met DSM-IV criteria for current alcohol abuse or dependence (80%
for abuse, 70% for dependence);
• mean ± SD number of drinking days in the past 30 days prior to baseline
assessment: 12.0 ± 10.3;
• 71.4% of quantities on all drinking days exceeded conventional criteria defining
heavy alcohol consumption (5+ drinks for men and 3+ drinks for women);
• mean ± SD drinks per drinking days 7.3 ± 5.8.
Interventions (1) MI group: focus on alcohol use and HIV risk-taking (n = 95)
Goals: to assess the degree to which the participant engages in hazardous drinking; to
identify relationships between alcohol consumption and alcohol-related negative conse-
quences including HIV risk behaviour; to identify goals for behaviour change and any
barriers to change
• Included a written change plan, designed to reduce the link between alcohol
consumption and hazardous behaviours that may lead to negative consequences of
drinking, including HIV risk behaviour
• Interventionist trained by studying the manual and watching MI tapes from
Project MATCH
• Standard delivery of the MI protocol
• Adherence monitoring by: an MI checklist completed by the therapist after each
session and audiotapes of sessions were randomly reviewed by a supervisor trained in
MI
(2) Control group: assessment-only, approximately 3 hours (n = 92)
Duration of the intervention: 2 therapist sessions, 1month apart; 1st session: 60minutes,
2nd session: 30 to 45 minutes
Duration of follow-up: 1 and 6 months
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Country of origin, setting: NEP clients, study site: Rhode Island Hospital in Providence,
USA
Outcomes • Alcohol use as number of days in the past 30 days with alcohol use at 1 month
• Alcohol use as number of days in the past 30 days with alcohol use at 6 months
• Alcohol use as 25% reduction of drinking days in the past 30 days
• Alcohol use as 50% reduction of drinking days in the past 30 days
• Alcohol use as 75% reduction of drinking days in the past 30 days
• Alcohol use as 1 or more drinking days’ reduction in the past 30 days
• Alcohol use as 7 or more drinking days’ reduction in the past 30 days
• Number of days in the past 30 days with IRRB - defined as answer to a question:
”Have you used needles etc. after someone else?“ (reported only for a subset of 109
participants in the Stein 2002b paper).
• Retention - end of treatment
Notes Control and MI subjects received identical research assessments at baseline, 1 and 6
months:
• at baseline and 1 month later, both MI and control group received a list of
referrals for substance abuse and medical treatment;
• participants in the control group spent approximately 3 total hours (assessment
time) with research staff, ”the assessment included sections on demographics, drug and
alcohol use, drug and alcohol treatment, health-related quality of life, attitudes and
experiences with alcohol and HIV risk behavior“;
• the assessment control group also experienced meaningful reduction in alcohol
use;
• 6-month follow up: 11 subjects were interviewed in prison and 6 were
interviewed by telephone;
• total reimbursement: $90 with $20 given at baseline, $30 at the 1-month
interview and $40 at the final interview;
• 65 (34.8%) participants reported 4 or fewer drinking days at baseline: their
maximum possible decrease in drinking days at follow-up is 4 or less (i.e. floor and
ceiling effects);
• change in heroin use was not associated with change in alcohol use;
• the association between change in IRRB days and change in alcohol use days was
not statistically significant.
• The paper reporting IRRB outcomes (Stein 2002b) was included in another
Cochrane Review (Meader 2010); therefore, it was not considered for this review.
• The study was funded by National Institutes of Health; information on conflicts
of interest was not provided.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not enough information provided: ”Fol-
lowing the baseline interview subjects were
assigned to treatment conditions using a
randomisation schedule created with per-
muted blocks of eight assignments.“ ”After
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randomisation, the research interventionist
saw participants assigned to MI...“
Allocation concealment (selection bias) Unclear risk Not stated how the randomisation sched-
ule was prepared: ”This method ensured
that the treatment groups were balanced in
number to within four patients through-
out the trial. The data manager prepared
the randomisation schedule before the first
patient enrolled“
Blinding of outcome assessment (detection
bias)
Subjective outcomes
Low risk ”At each follow-up assessment, research as-
sistants were blinded to the treatment con-
dition of the subject; the interventionist did
not perform research assessments“
Incomplete outcome data (attrition bias)
End of Study outcomes
Unclear risk Not available. The study did not assess out-
comes at the time of the study end
Incomplete outcome data (attrition bias)
Follow up
Low risk ”We conducted an intent-to-treat analysis
using a conservative ’worst case scenario’
strategy inwhich observationswithmissing
follow-up datawere assigned themaximum
value of 30 drinking days, a data imputa-
tion approach which tends tominimize ob-
served reductions in mean drinking days
across time
To ensure that our substantive results were
not sensitive to missing observations (there
were no condition differences in missing
data) we replicated our analyses using ob-
servations with complete data (n = 181),
and using other imputation strategies (e.
g. mean substitution, regression estimation
and ’best case scenario’). All imputation
strategies resulted in substantively consis-
tent findings
To evaluate the adequacy of random as-
signment, we used t- and x2-tests to com-
pare treatment groups with respect to back-
ground characteristics and baseline mea-
sures of drinking behaviours and alcohol
problems“
Number of dropouts and reasons:
There were no study withdrawals: 93 of 95
in the MI group received both MI sessions:
2 people missed their second session. 6-
month follow-updatawere available for 96.
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8% (n = 181) of the 187 randomly assigned
subjects. 3 subjects in each treatment arm
were lost to follow-up at 6 months
Selective reporting (reporting bias) Low risk
ASI: Addiction Severity Index; ASSIST: Alcohol, Smoking and Substance Involvement Screening Test; ASP: antisocial personality
disorder; BAL: blood alcohol level; BI: brief intervention; CBCST: cognitive-behavioural coping skills training; CBT: cognitive
behavioural therapy; CM: clinical management; DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders, Third Edition
- Revised; DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition; HCV: hepatitis C virus; HIV: human
immunodeficiency virus; HHP: hepatitis health promotion; ICD-10: International Classification of Diseases - Tenth Revision;
IDU: injection drug use; ITT: intention to treat; IRRB: injection-related HIV risk behaviour; MI: motivational intervention;
MSW: master in social work; NEP: needle exchange programme; PhD: doctor of philosophy; PWID: people who use illicit drugs;
RCT: randomised controlled trial; SD: standard deviation; TAU: treatment as usual; TLFB: timeline follow-back; TSF: twelve-step
facilitation programme; UCG: usual care group; WHO: World Health Organization.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Aldridge 2017 Participants did not meet our inclusion criteria: concurrent problem alcohol use was not an inclusion criterion.
Excluded in 2017
Aldridge 2017b Participants did not meet our inclusion criteria: concurrent problem alcohol use was not an inclusion criterion.
Excluded in 2017
Bennett 2002 Study design did not meet our inclusion criteria: not an RCT
Bernstein 2005 Outcome did not meet our inclusion criteria: alcohol use was not measured, because the intervention focused on
drug use and the participants were not reported to have problem alcohol use at randomisation
Bowen 2006 Study design did not meet our inclusion criteria: not an RCT
Chambers 2016 Participants did not meet our inclusion criteria: concurrent problem alcohol use was not an inclusion criterion.
Excluded in 2017
Cohen 1982 Participants did not meet our inclusion criteria: concurrent problem alcohol use not an inclusion criterion for all
subjects randomised into trial. Quote: ”Approximately one-third of all the active alcoholics [n=105] were assigned
to each of the three study groups (1983, p864; 1982, p360).“ Comment: it is highly probable that non-alcoholics
were randomised into trial. Operative alcoholics (N = 105) versus all subjects randomised into trial (N = 127)
Darker 2016a Study design did not meet our inclusion criteria: concurrent problem alcohol use was not an inclusion criterion.
Excluded in 2017
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Drumright 2011 Study design did not meet our inclusion criteria: not an RCT. A secondary analysis of 2 RCTs that did not have
concurrent problem alcohol use not an inclusion criterion
Karno 2017 Participants did not meet our inclusion criteria: concurrent problem alcohol use was not an inclusion criterion.
Excluded in 2017
Kennedy 2016 Participants did not meet our inclusion criteria: concurrent problem alcohol use was not an inclusion criterion.
Excluded in 2017
Moyers 2016 Participants did not meet our inclusion criteria: concurrent problem alcohol use was not an inclusion criterion.
Excluded in 2017
O’Farrell 2008 Participants did not meet our inclusion criteria: participants were eligible if they had alcohol dependence diagnosis
with or without comorbid drug diagnosis
Worden 2010 Participants did not meet our inclusion criteria: concurrent problem alcohol use was not an inclusion criterion.
Additionally, 46.6% reported alcohol as their primary drug (review exclusion criterion)
RCT: randomised controlled trial.
Characteristics of studies awaiting assessment [ordered by study ID]
Aharonovich 2017
Methods Participants were HIV+ binge drinking, non-injection drug users recruited in New York City via newspaper ads (N
= 47)
They were randomised to brief MI-only (n = 21) or BMI + HealthCall (n = 21)
Participants Mean age was 50.8 (SD = 7.13), 71% were male, 76% African-American, 7% employed, primary drug crack (92.
8%)
At baseline, mean days of drug use in past 30 days was 14.05 (SD = 6.1), mean drinking days 13.95 (SD = 6.7)
Interventions (1) Authors adapted their technology-based intervention, called “HealthCall”, to enhance and extend brief motiva-
tional interviewing (BMI) to target concurrent drug and alcohol use in HIV+ individuals
(2) HealthCall involves 60 days of daily self-monitoring of alcohol and drug use and
related behaviours via smartphone app with video, positive reinforcements and personalized feedback
Outcomes Of the 42 individuals who initiated treatment, all (100%) completed the study
The majority of participants were highly engaged in HealthCall; those randomised to it used it a mean of 89.6% of
all possible days
At end of treatment (60 days), participants assigned toMI + HealthCall had fewer days of primary drug use than the
BMI-only group (4.95 [SD = 4.7] days vs. 8.3 [SD = 6.1]) days, respectively (P = 0.06)
Those in BMI + HealthCall also had fewer drinking days (mean 7.04 days; SD = 7.6) vs. the BMI-only group (8.14
days; SD 5.7) (P = 0.09)
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Notes Conference abstract only; full report not published yet:
”A larger randomized trial is warranted to replicate and extend the present results in a larger sample.“ (P.256A)
Columbia University Medical Center, Psychiatry Department, New York, NY, 10032, USA
Poblete 2017
Methods A multicenter randomised open-label trial stratified using the ASSIST-specific substance involvement score (for
alcohol, scores ranged from 11 to 15 and 16 to 20; and for the other substances from 4 to 12 and 13 to 20)
Participants A total of 19 primary care centres (n = 520), eight emergency rooms (n = 195) and five police stations (n = 91) were
evaluated. A total of 12 217 people aged between 19 and 55 years were screened for moderate alcohol and drug use
risk as defined by the ASSIST Chilean version
A total of 806 non-treatment-seekers were randomised.
Interventions ASSIST-linked BI (n = 400) compared with an informational pamphlet on risk associated with substance use (n =
406)
Outcomes Total ASSIST alcohol (Al) and illicit involvement score (ASSIST-AI), and ASSIST-specific score for alcohol, cannabis
and cocaine at baseline and at 3-month follow-up
Notes We asked the authors about the data for a subsample of primary-care patients who had ASSIST-cocaine positive. The
analysis showed no difference between the two groups for the ASSIST- for specific scores alcohol (MD = 0.18, CI =
-1.45, 1.10), or cocaine (MD = -0.79, CI = -2.89, 4.47).
62% of participants completed 3-month follow-up (38% study attrition)
Staiger 2011
Methods Randomised controlled trial of a brief alcohol intervention programme for adults in residential drug treatment
Participants N = 166 adults, meeting DSM-IV diagnostic criteria for substance dependence in the past 12 months, recruited from
2 Therapeutic Communities (TC) in Victoria; average length of residential stay was 8.7 months (21-974 days)
Most were single, male Australians with some high school education
• From the table 4 (p28), it would occur that alcohol was the primary problem drug for 22 participants (10 and
12).
• Also, 89% of the control group, and 90.5% of the experimental group, reported using alcohol in the 3 months
prior to intake (p29).
• Also, 45 had severe alcohol dependency (21 and 24) (p31), as per SADQ (score > 30 indicates severe alcohol
dependence).
Interventions Alcohol intervention group (AIG experimental) vs. Basic education group (EDU control)
1) AIG experimental: Mindfulness-based Relapse Prevention
• Responsible Drinking Program, based on the Alcohol Skills Training Program (ASTP, developed for US college
students by Marlatt et al.)
• Designed to progressively build upon a participants’ knowledge and skills. Group sessions aimed to equip
them to: 1) use mindfulness strategies to manage emotional states, to 2) understand motives and expectations about
alcohol, to 3) ensure adequate knowledge of the effects of alcohol and to 4) manage personal and social situations in
relation to alcohol use;
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• Basic principles of Dialectical Behaviour Therapy (Marsha Linehan)
• Mindfulness skills training, comprised a key part of the final 3 sessions of the program;
• A manual guided group facilitators. Facilitators received weekly supervision to monitor and guide their AIG
group work. Goups were routinely digitally recorded to ensure fidelity of program content.
• Participants had a workbook to act as a resource and reminder of program content. A mindfulness exercise CD
was created which was included in the workbook provided to the AIG group.
• 5 group sessions (weekly; 3-6 weeks after start of residential treatment);
• plus 2 check in calls, (2 weeks apart) after EXIT, reviewed drinking;
• plus 6 therapeutic letters, which were mailed to participants at six weekly intervals, whilst they remained in
the residential treatment program, and aimed to minimise the reduction of treatment effect over time, reminding
clients of the activities, skills and personal goals.
2) EDU control: basic education
• Semi-structured
• Standard drink
• Effects of alcohol on person
• Low risk drink guidelines
• Basic alcohol education (which we manualised in order to standardise that component).
• Conducted over 2 group sessions (1 week apart) and was similar in content to a drink driving alcohol
education.
• All TC residents were invited to attend the Alcohol Intervention Study as management of the TC did not
want those with an alcohol primary problem to be treated differently within a TC setting.
• We designed the interventions to take into account different drinking goals (i.e. abstinence and moderate
drinking); however, the primary focus of the program was on those with a dependent drug problem.
Outcomes • AUDIT
• SADQ/SADQ-C (p.31 of the final project report)
• TLFB- 90 days recall
• SDS (p.32 of the final project report)
• ASI- alcohol (5th edition)
• Social functioning: Index of OTI
• Mental health defined as: number of days with significant psychological problem in past month (ASI - single
item)
• Average standard drinks consumed per drinking day in the 90 days prior to each assessment point (Table 8, of
the final project report).
• No of drinking days in the 90 days prior to each assessment point (Table 9).
• Average days heroin use in the 3 months prior to each assessment point (Table 14).
Notes Include if authors provide unpublished data for the subsample of AUDIT-positive participants. Final study report
gives results for all participants together, including people with and without alcohol problems
Alcohol was used only by 149 of the 166 participants in the 90 days prior to initial presentation. The full, unpublished
report (2010) of this study (Staiger 2009) was considered during the 2017 update of this review and the study is
among studies awaiting classification
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Thapaliya 2017
Methods Randomised trial
Participants 43 patients receiving Buprenorphine-Naloxone agonist treatment
Inclusion criteria:
• ASSIST-alcohol score > 11;
• male patients, 18-60 years;
• file diagnosis: Opioid Dependence Syndrome;
• receiving buprenorphine treatment for at least 3 months;
• receiving buprenorphine from NDDTC pharmacy;
• has taken medication on at least 50% of the days in last one month.
Exclusion criterion:
• file diagnosis of comorbidity (other substance abuse or dependence, or psychiatric co-morbidity on Axis 1,
except alcohol and tobacco).
Sample characteristics
• 100% males
• Mean age: 41.5 years
• Married: 78%
• Urban Residence: 68%
• Employed: 87.5%
• Weekly dispensing of Buprenorphine: 90%
• Mean duration of maintenance treatment: 56 months (~5 years)
• Mean dose of Buprenorphine: 11.5 mg/day
Setting: National Drug Dependence Treatment Centre (NDDTC), All-India Institute of Medical Sciences (AIIMS)
, New Delhi, India
Interventions (1) ASSIST brief intervention (n = 22)
(2) Simple advice (n = 21, wait list control)
Outcomes • ASSIST scores (the BI group had mean reduction in ASSIST score 7.7 [± 3.67] at 3 months)
• bio-markers of change in alcohol use (AST, ALT, GGT, MCV, CDT)
Notes One BI participant lost to follow up.
All those who received SA also received BI at follow up.
Conference abstract only (Thapaliya 2017); full report not published yet.
Other related abstracts presented at the Lisbon addictions 2017 conference:
• Screening for continued substance use among subjects on buprenorphine maintenance treatment: a cross-
sectional study. Suresh Thapaliya, Nepal (poster)
• Screening for moderate/high risk alcohol use among opioid dependent patients on buprenorphine
maintenance: a clinical and alcohol-biomarker study. Suresh Thapaliya, Nepal (oral presentation)
HIV+: Human Imunodeficiency Virus positive; MI-only: Motivational Intereviewing-only; BMI: Brief Motivational Interviewing;
SD: Standard Deviation; ASSIST: Alcohol, Smoking and Substance Involvement Screening Test; BI: Brief Intervention; MD: Mean
Difference; Alcohol intervention group (AIG experimental) vs. Basic education group (EDU control);Alcohol Skills Training Program
(ASTP,; OTI: ˙˙; SADQ: Substance Abuse Dependence Questionnaire; SDS: Severity of Dependence Scale; ASI: Addiction Severity
Index; AUDIT: Alcohol Use Disorders Identification Test; CD: Compact Disc; TLFB: Time Line Follow Back; TC: Therapeutic
Communities; DSM-IV: Diagnostic and Statistical Manual Fourth version; SA: Simple Advice; AST: Aspartate Aminotransferase;
ALT: Alanine Aminotransferase; GGT: gamma-glutamyl transferase; MCV: Mean Corpuscular Volume; CDT: Carbohydrate-defi-
cient transferrin; NDDTC: National Drug Dependence Treatment Centre; AIIMS: All-India Institute of Medical Sciences.
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D A T A A N D A N A L Y S E S
Comparison 1. Cognitive-behavioural coping skills training (CBCST) versus twelve-step facilitation (TSF) pro-
gramme
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Alcohol abstinence as number
achieving 3 or more weeks of
consecutive alcohol abstinence
during treatment
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
2 Alcohol abstinence as maximum
number of weeks of consecutive
alcohol abstinence during
treatment
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
3 Alcohol abstinence during
follow-up year
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
4 Retention - end of treatment
(unpublished)
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
5 Illicit drug abstinence as
maximum number of weeks of
consecutive abstinence from
cocaine during treatment
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
6 Illicit drug abstinence as number
achieving 3 or more weeks of
consecutive abstinence from
cocaine during treatment
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
7 Illicit drug abstinence as
abstinence from cocaine during
follow-up year
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
Comparison 2. Brief intervention (BI) versus treatment as usual (TAU)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Alcohol use as AUDIT or
ASSIST scores at 3 months
3 170 Std. Mean Difference (IV, Random, 95% CI) 0.07 [-0.24, 0.37]
2 Alcohol use as AUDIT scores at
9 months
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
3 Alcohol use as decreased alcohol
use at 3 months
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
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4 Alcohol use as number of drinks
per week at 3 months
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
5 Alcohol use as number of drinks
per week at 9 months
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
6 Alcohol use as decreased alcohol
use at 9 months
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
7 Retention at 3 months
(unpublished and published
data)
3 190 Risk Ratio (M-H, Random, 95% CI) 0.94 [0.78, 1.13]
Comparison 3. Motivational interviewing (MI) versus treatment as usual (TAU) or educational intervention only
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Alcohol use as AUDIT or
ASSIST scores at 3 months
2 141 Std. Mean Difference (IV, Random, 95% CI) 0.04 [-0.29, 0.37]
2 Alcohol use as AUDIT scores at
9 months
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
3 Alcohol use as number of
standard drinks consumed per
day over the last 30 days
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
4 Alcohol use as number of drinks
per week at 3 months
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
5 Alcohol use as number of drinks
per week at 9 months
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
6 Alcohol use as greater than
50% reduction in number of
standard drinks consumed per
day over the last 30 days
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
7 Alcohol abstinence as abstinence
from alcohol over the last 30
days
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
8 Alcohol use as decreased alcohol
use at 3 months
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
9 Alcohol use as decreased alcohol
use at 9 months
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
10 Retention - end of treatment 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
11 Retention at 3 months
(unpublished and published
data)
2 160 Risk Ratio (M-H, Random, 95% CI) 0.93 [0.60, 1.43]
12 Illicit drug use as frequency
of drug use (as measured by
Addiction Severity Index - ASI
drug)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
13 Illicit drug use as a composite
drug score (frequency*severity
for all drugs taken)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
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Comparison 4. Brief motivational interviewing (BMI) versus assessment-only
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Alcohol use as number of days in
the past 30 days with alcohol
use at 1 month
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
2 Alcohol use as number of days in
the past 30 days with alcohol
use at 6 months
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
3 Alcohol use as 25% reduction
of drinking days in the past 30
days
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
4 Alcohol use as 50% reduction
of drinking days in the past 30
days
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
5 Alcohol use as 75% reduction
of drinking days in the past 30
days
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
6 Alcohol use as 1 or more
drinking days’ reduction in the
past 30 days
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
7 Alcohol use as 7 or more
drinking days’ reduction in the
past 30 days
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
8 Retention - end of treatment 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
Comparison 5. Motivational interviewing intensive (MII) versus motivational interviewing (MI)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Alcohol addiction severity as ASI
alcohol score at 2 months
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
2 Alcohol addiction severity as ASI
alcohol score at 4 months
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
3 Alcohol addiction severity as ASI
alcohol score at 6 months
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
4 Retention - end of treatment
(unpublished)
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
5 Drug abstinence as % days
methamphetamine abstinent in
the last 6 months (TLFB)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
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Analysis 1.1. Comparison 1 Cognitive-behavioural coping skills training (CBCST) versus twelve-step
facilitation (TSF) programme, Outcome 1 Alcohol abstinence as number achieving 3 or more weeks of
consecutive alcohol abstinence during treatment.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 1 Cognitive-behavioural coping skills training (CBCST) versus twelve-step facilitation (TSF) programme
Outcome: 1 Alcohol abstinence as number achieving 3 or more weeks of consecutive alcohol abstinence during treatment
Study or subgroup CBCST TSF Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Carroll 1998 5/23 2/18 1.96 [ 0.43, 8.94 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours CBCST Favours TSF
Analysis 1.2. Comparison 1 Cognitive-behavioural coping skills training (CBCST) versus twelve-step
facilitation (TSF) programme, Outcome 2 Alcohol abstinence as maximum number of weeks of consecutive
alcohol abstinence during treatment.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 1 Cognitive-behavioural coping skills training (CBCST) versus twelve-step facilitation (TSF) programme
Outcome: 2 Alcohol abstinence as maximum number of weeks of consecutive alcohol abstinence during treatment
Study or subgroup CBCST TSF
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Carroll 1998 23 2.2 (3) 18 1.8 (2) 0.40 [ -1.14, 1.94 ]
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours CBCST Favours TSF
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Analysis 1.3. Comparison 1 Cognitive-behavioural coping skills training (CBCST) versus twelve-step
facilitation (TSF) programme, Outcome 3 Alcohol abstinence during follow-up year.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 1 Cognitive-behavioural coping skills training (CBCST) versus twelve-step facilitation (TSF) programme
Outcome: 3 Alcohol abstinence during follow-up year
Study or subgroup CBCST TSF Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Carroll 1998 1/23 0/18 2.38 [ 0.10, 55.06 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours CBCST Favours TSF
Analysis 1.4. Comparison 1 Cognitive-behavioural coping skills training (CBCST) versus twelve-step
facilitation (TSF) programme, Outcome 4 Retention - end of treatment (unpublished).
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 1 Cognitive-behavioural coping skills training (CBCST) versus twelve-step facilitation (TSF) programme
Outcome: 4 Retention - end of treatment (unpublished)
Study or subgroup CBCST TSF Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Carroll 1998 16/23 14/18 0.89 [ 0.62, 1.29 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours CBCST Favours TSF
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Analysis 1.5. Comparison 1 Cognitive-behavioural coping skills training (CBCST) versus twelve-step
facilitation (TSF) programme, Outcome 5 Illicit drug abstinence as maximum number of weeks of consecutive
abstinence from cocaine during treatment.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 1 Cognitive-behavioural coping skills training (CBCST) versus twelve-step facilitation (TSF) programme
Outcome: 5 Illicit drug abstinence as maximum number of weeks of consecutive abstinence from cocaine during treatment
Study or subgroup CBCST TSF
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Carroll 1998 23 2.1 (3.4) 18 1.3 (1.2) 0.80 [ -0.70, 2.30 ]
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours CBCST Favours TSF
Analysis 1.6. Comparison 1 Cognitive-behavioural coping skills training (CBCST) versus twelve-step
facilitation (TSF) programme, Outcome 6 Illicit drug abstinence as number achieving 3 or more weeks of
consecutive abstinence from cocaine during treatment.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 1 Cognitive-behavioural coping skills training (CBCST) versus twelve-step facilitation (TSF) programme
Outcome: 6 Illicit drug abstinence as number achieving 3 or more weeks of consecutive abstinence from cocaine during treatment
Study or subgroup CBCST TSF Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Carroll 1998 7/23 5/18 1.10 [ 0.42, 2.88 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours CBCST Favours TSF
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Analysis 1.7. Comparison 1 Cognitive-behavioural coping skills training (CBCST) versus twelve-step
facilitation (TSF) programme, Outcome 7 Illicit drug abstinence as abstinence from cocaine during follow-up
year.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 1 Cognitive-behavioural coping skills training (CBCST) versus twelve-step facilitation (TSF) programme
Outcome: 7 Illicit drug abstinence as abstinence from cocaine during follow-up year
Study or subgroup CBCST TSF Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Carroll 1998 1/23 2/18 0.39 [ 0.04, 3.98 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours TSF Favours CBCST
Analysis 2.1. Comparison 2 Brief intervention (BI) versus treatment as usual (TAU), Outcome 1 Alcohol
use as AUDIT or ASSIST scores at 3 months.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 2 Brief intervention (BI) versus treatment as usual (TAU)
Outcome: 1 Alcohol use as AUDIT or ASSIST scores at 3 months
Study or subgroup BI TAU
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Darker 2016 13 19.8 (10) 18 21.5 (12.5) 18.0 % -0.14 [ -0.86, 0.57 ]
Feldman 2013 59 13 (6.2) 51 12.4 (7.5) 65.3 % 0.09 [ -0.29, 0.46 ]
Henihan 2016 12 13.5 (9.3) 17 11.5 (9.5) 16.7 % 0.21 [ -0.53, 0.95 ]
Total (95% CI) 84 86 100.0 % 0.07 [ -0.24, 0.37 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.48, df = 2 (P = 0.79); I2 =0.0%
Test for overall effect: Z = 0.42 (P = 0.67)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours BI Favours TAU
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Analysis 2.2. Comparison 2 Brief intervention (BI) versus treatment as usual (TAU), Outcome 2 Alcohol
use as AUDIT scores at 9 months.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 2 Brief intervention (BI) versus treatment as usual (TAU)
Outcome: 2 Alcohol use as AUDIT scores at 9 months
Study or subgroup BI TAU
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Feldman 2013 59 13.9 (8.1) 51 11.6 (7.3) 2.30 [ -0.58, 5.18 ]
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours BI Favours TAU
Analysis 2.3. Comparison 2 Brief intervention (BI) versus treatment as usual (TAU), Outcome 3 Alcohol
use as decreased alcohol use at 3 months.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 2 Brief intervention (BI) versus treatment as usual (TAU)
Outcome: 3 Alcohol use as decreased alcohol use at 3 months
Study or subgroup BI TAU Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Feldman 2013 21/59 16/51 1.13 [ 0.67, 1.93 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours BI Favours TAU
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Analysis 2.4. Comparison 2 Brief intervention (BI) versus treatment as usual (TAU), Outcome 4 Alcohol
use as number of drinks per week at 3 months.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 2 Brief intervention (BI) versus treatment as usual (TAU)
Outcome: 4 Alcohol use as number of drinks per week at 3 months
Study or subgroup BI TAU
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Feldman 2013 59 17 (11.6) 51 16.3 (12.6) 0.70 [ -3.85, 5.25 ]
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours BI Favours TAU
Analysis 2.5. Comparison 2 Brief intervention (BI) versus treatment as usual (TAU), Outcome 5 Alcohol
use as number of drinks per week at 9 months.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 2 Brief intervention (BI) versus treatment as usual (TAU)
Outcome: 5 Alcohol use as number of drinks per week at 9 months
Study or subgroup BI TAU
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Feldman 2013 59 18.4 (10.4) 51 18.7 (13.2) -0.30 [ -4.79, 4.19 ]
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours BI Favours TAU
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Analysis 2.6. Comparison 2 Brief intervention (BI) versus treatment as usual (TAU), Outcome 6 Alcohol
use as decreased alcohol use at 9 months.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 2 Brief intervention (BI) versus treatment as usual (TAU)
Outcome: 6 Alcohol use as decreased alcohol use at 9 months
Study or subgroup BI TAU Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Feldman 2013 19/59 15/51 1.09 [ 0.62, 1.92 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours BI Favours TAU
Analysis 2.7. Comparison 2 Brief intervention (BI) versus treatment as usual (TAU), Outcome 7 Retention
at 3 months (unpublished and published data).
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 2 Brief intervention (BI) versus treatment as usual (TAU)
Outcome: 7 Retention at 3 months (unpublished and published data)
Study or subgroup BI TAU Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Darker 2016 21/21 29/29 48.4 % 1.00 [ 0.92, 1.08 ]
Feldman 2013 29/59 30/51 18.5 % 0.84 [ 0.59, 1.18 ]
Henihan 2016 12/13 17/17 33.1 % 0.92 [ 0.75, 1.12 ]
Total (95% CI) 93 97 100.0 % 0.94 [ 0.78, 1.13 ]
Total events: 62 (BI), 76 (TAU)
Heterogeneity: Tau2 = 0.02; Chi2 = 5.76, df = 2 (P = 0.06); I2 =65%
Test for overall effect: Z = 0.65 (P = 0.51)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours BI Favours TAU
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Analysis 3.1. Comparison 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational
intervention only, Outcome 1 Alcohol use as AUDIT or ASSIST scores at 3 months.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational intervention only
Outcome: 1 Alcohol use as AUDIT or ASSIST scores at 3 months
Study or subgroup MI TAU
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Darker 2016 13 19.8 (10) 18 21.5 (12.5) 21.6 % -0.14 [ -0.86, 0.57 ]
Feldman 2013 59 13 (6.2) 51 12.4 (7.5) 78.4 % 0.09 [ -0.29, 0.46 ]
Total (95% CI) 72 69 100.0 % 0.04 [ -0.29, 0.37 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.31, df = 1 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 0.22 (P = 0.83)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours BI Favours TAU
Analysis 3.2. Comparison 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational
intervention only, Outcome 2 Alcohol use as AUDIT scores at 9 months.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational intervention only
Outcome: 2 Alcohol use as AUDIT scores at 9 months
Study or subgroup BI TAU
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Feldman 2013 59 13.9 (8.1) 51 11.6 (7.3) 2.30 [ -0.58, 5.18 ]
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours BI Favours TAU
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Analysis 3.3. Comparison 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational
intervention only, Outcome 3 Alcohol use as number of standard drinks consumed per day over the last 30
days.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational intervention only
Outcome: 3 Alcohol use as number of standard drinks consumed per day over the last 30 days
Study or subgroup MI Education
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Nyamathi 2010 148 3.7 (4.5) 77 3.9 (6.2) -0.20 [ -1.76, 1.36 ]
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours MI Favours Education
Analysis 3.4. Comparison 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational
intervention only, Outcome 4 Alcohol use as number of drinks per week at 3 months.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational intervention only
Outcome: 4 Alcohol use as number of drinks per week at 3 months
Study or subgroup BI TAU
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Feldman 2013 59 17 (11.6) 51 16.3 (12.6) 0.70 [ -3.85, 5.25 ]
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours BI Favours TAU
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Analysis 3.5. Comparison 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational
intervention only, Outcome 5 Alcohol use as number of drinks per week at 9 months.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational intervention only
Outcome: 5 Alcohol use as number of drinks per week at 9 months
Study or subgroup BI TAU
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Feldman 2013 59 18.4 (10.4) 51 18.7 (13.2) -0.30 [ -4.79, 4.19 ]
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours BI Favours TAU
Analysis 3.6. Comparison 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational
intervention only, Outcome 6 Alcohol use as greater than 50% reduction in number of standard drinks
consumed per day over the last 30 days.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational intervention only
Outcome: 6 Alcohol use as greater than 50% reduction in number of standard drinks consumed per day over the last 30 days
Study or subgroup MI Education Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Nyamathi 2010 84/169 43/87 1.01 [ 0.77, 1.31 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours MI Favours Education
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Analysis 3.7. Comparison 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational
intervention only, Outcome 7 Alcohol abstinence as abstinence from alcohol over the last 30 days.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational intervention only
Outcome: 7 Alcohol abstinence as abstinence from alcohol over the last 30 days
Study or subgroup MI Education Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Nyamathi 2010 36/169 20/87 0.93 [ 0.57, 1.50 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours MI Favours Education
Analysis 3.8. Comparison 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational
intervention only, Outcome 8 Alcohol use as decreased alcohol use at 3 months.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational intervention only
Outcome: 8 Alcohol use as decreased alcohol use at 3 months
Study or subgroup BI TAU Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Feldman 2013 21/59 16/51 1.13 [ 0.67, 1.93 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours BI Favours TAU
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Analysis 3.9. Comparison 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational
intervention only, Outcome 9 Alcohol use as decreased alcohol use at 9 months.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational intervention only
Outcome: 9 Alcohol use as decreased alcohol use at 9 months
Study or subgroup BI TAU Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Feldman 2013 19/59 15/51 1.09 [ 0.62, 1.92 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours BI Favours TAU
Analysis 3.10. Comparison 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational
intervention only, Outcome 10 Retention - end of treatment.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational intervention only
Outcome: 10 Retention - end of treatment
Study or subgroup MI Education Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Nyamathi 2010 144/169 77/87 0.96 [ 0.87, 1.06 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours MI Favours Education
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Analysis 3.11. Comparison 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational
intervention only, Outcome 11 Retention at 3 months (unpublished and published data).
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational intervention only
Outcome: 11 Retention at 3 months (unpublished and published data)
Study or subgroup BI TAU Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Darker 2016 21/21 29/29 57.5 % 1.00 [ 0.92, 1.08 ]
Feldman 2013 29/59 30/51 42.5 % 0.84 [ 0.59, 1.18 ]
Total (95% CI) 80 80 100.0 % 0.93 [ 0.60, 1.43 ]
Total events: 50 (BI), 59 (TAU)
Heterogeneity: Tau2 = 0.08; Chi2 = 6.04, df = 1 (P = 0.01); I2 =83%
Test for overall effect: Z = 0.35 (P = 0.73)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours BI Favours TAU
Analysis 3.12. Comparison 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational
intervention only, Outcome 12 Illicit drug use as frequency of drug use (as measured by Addiction Severity
Index - ASI drug).
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational intervention only
Outcome: 12 Illicit drug use as frequency of drug use (as measured by Addiction Severity Index - ASI drug)
Study or subgroup MI Education
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Nyamathi 2010 148 0.1 (0.1) 77 0.1 (0.1) 0.0 [ -0.03, 0.03 ]
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours MI Favours Education
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Analysis 3.13. Comparison 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational
intervention only, Outcome 13 Illicit drug use as a composite drug score (frequency*severity for all drugs
taken).
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 3 Motivational interviewing (MI) versus treatment as usual (TAU) or educational intervention only
Outcome: 13 Illicit drug use as a composite drug score (frequency*severity for all drugs taken)
Study or subgroup MI Education
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Nyamathi 2010 150 1.1 (1.3) 79 1.1 (1.2) 0.0 [ -0.34, 0.34 ]
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours MI Favours Education
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Analysis 4.1. Comparison 4 Brief motivational interviewing (BMI) versus assessment-only, Outcome 1
Alcohol use as number of days in the past 30 days with alcohol use at 1 month.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 4 Brief motivational interviewing (BMI) versus assessment-only
Outcome: 1 Alcohol use as number of days in the past 30 days with alcohol use at 1 month
Study or subgroup BMI Assessment
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Stein 2002 95 11.1 (10.9) 92 11.4 (10.6) -0.30 [ -3.38, 2.78 ]
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours BMI Favours Assessment
Analysis 4.2. Comparison 4 Brief motivational interviewing (BMI) versus assessment-only, Outcome 2
Alcohol use as number of days in the past 30 days with alcohol use at 6 months.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 4 Brief motivational interviewing (BMI) versus assessment-only
Outcome: 2 Alcohol use as number of days in the past 30 days with alcohol use at 6 months
Study or subgroup BMI Assessment
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Stein 2002 95 7.6 (10.3) 92 9.1 (11) -1.50 [ -4.56, 1.56 ]
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours BMI Favours Assessment
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Analysis 4.3. Comparison 4 Brief motivational interviewing (BMI) versus assessment-only, Outcome 3
Alcohol use as 25% reduction of drinking days in the past 30 days.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 4 Brief motivational interviewing (BMI) versus assessment-only
Outcome: 3 Alcohol use as 25% reduction of drinking days in the past 30 days
Study or subgroup BMI Assessment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Stein 2002 61/95 48/92 1.23 [ 0.96, 1.57 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours Assessment Favours BMI
Analysis 4.4. Comparison 4 Brief motivational interviewing (BMI) versus assessment-only, Outcome 4
Alcohol use as 50% reduction of drinking days in the past 30 days.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 4 Brief motivational interviewing (BMI) versus assessment-only
Outcome: 4 Alcohol use as 50% reduction of drinking days in the past 30 days
Study or subgroup BMI Assessment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Stein 2002 55/95 42/92 1.27 [ 0.96, 1.68 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours Assessment Favours BMI
83Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 4.5. Comparison 4 Brief motivational interviewing (BMI) versus assessment-only, Outcome 5
Alcohol use as 75% reduction of drinking days in the past 30 days.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 4 Brief motivational interviewing (BMI) versus assessment-only
Outcome: 5 Alcohol use as 75% reduction of drinking days in the past 30 days
Study or subgroup BMI Assessment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Stein 2002 40/95 32/92 1.21 [ 0.84, 1.75 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours Assessment Favours BMI
Analysis 4.6. Comparison 4 Brief motivational interviewing (BMI) versus assessment-only, Outcome 6
Alcohol use as 1 or more drinking days’ reduction in the past 30 days.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 4 Brief motivational interviewing (BMI) versus assessment-only
Outcome: 6 Alcohol use as 1 or more drinking days’ reduction in the past 30 days
Study or subgroup BMI Assessment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Stein 2002 66/95 57/92 1.12 [ 0.91, 1.38 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours Assessment Favours BMI
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Analysis 4.7. Comparison 4 Brief motivational interviewing (BMI) versus assessment-only, Outcome 7
Alcohol use as 7 or more drinking days’ reduction in the past 30 days.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 4 Brief motivational interviewing (BMI) versus assessment-only
Outcome: 7 Alcohol use as 7 or more drinking days’ reduction in the past 30 days
Study or subgroup BMI Assessment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Stein 2002 38/95 22/92 1.67 [ 1.08, 2.60 ]
0.01 0.1 1 10 100
Favours Assessment Favours BMI
Analysis 4.8. Comparison 4 Brief motivational interviewing (BMI) versus assessment-only, Outcome 8
Retention - end of treatment.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 4 Brief motivational interviewing (BMI) versus assessment-only
Outcome: 8 Retention - end of treatment
Study or subgroup BMI Assessment Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Stein 2002 93/95 92/92 0.98 [ 0.94, 1.02 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours Assessment Favours BMI
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Analysis 5.1. Comparison 5 Motivational interviewing intensive (MII) versus motivational interviewing (MI),
Outcome 1 Alcohol addiction severity as ASI alcohol score at 2 months.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 5 Motivational interviewing intensive (MII) versus motivational interviewing (MI)
Outcome: 1 Alcohol addiction severity as ASI alcohol score at 2 months
Study or subgroup MIG-intens MIG
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Korcha 2014 80 0.14 (0.16) 83 0.11 (0.135) 0.03 [ -0.02, 0.08 ]
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours MIG-intens Favours MIG
Analysis 5.2. Comparison 5 Motivational interviewing intensive (MII) versus motivational interviewing (MI),
Outcome 2 Alcohol addiction severity as ASI alcohol score at 4 months.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 5 Motivational interviewing intensive (MII) versus motivational interviewing (MI)
Outcome: 2 Alcohol addiction severity as ASI alcohol score at 4 months
Study or subgroup MIG-intens MIG
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Korcha 2014 80 0.15 (0.16) 83 0.16 (0.152) -0.01 [ -0.06, 0.04 ]
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours MIG-intens Favours MIG
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Analysis 5.3. Comparison 5 Motivational interviewing intensive (MII) versus motivational interviewing (MI),
Outcome 3 Alcohol addiction severity as ASI alcohol score at 6 months.
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 5 Motivational interviewing intensive (MII) versus motivational interviewing (MI)
Outcome: 3 Alcohol addiction severity as ASI alcohol score at 6 months
Study or subgroup MIG-intens MIG
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Korcha 2014 80 0.14 (0.15) 83 0.16 (0.179) -0.02 [ -0.07, 0.03 ]
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours MIG-intens Favours MIG
Analysis 5.4. Comparison 5 Motivational interviewing intensive (MII) versus motivational interviewing (MI),
Outcome 4 Retention - end of treatment (unpublished).
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 5 Motivational interviewing intensive (MII) versus motivational interviewing (MI)
Outcome: 4 Retention - end of treatment (unpublished)
Study or subgroup MIG-intens MIG Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Korcha 2014 8/80 0/83 17.63 [ 1.03, 300.48 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours MIG-intens Favours MIG
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Analysis 5.5. Comparison 5 Motivational interviewing intensive (MII) versus motivational interviewing (MI),
Outcome 5 Drug abstinence as % days methamphetamine abstinent in the last 6 months (TLFB).
Review: Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users
Comparison: 5 Motivational interviewing intensive (MII) versus motivational interviewing (MI)
Outcome: 5 Drug abstinence as % days methamphetamine abstinent in the last 6 months (TLFB)
Study or subgroup MIG-intens MIG
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Korcha 2014 80 76.4 (29.3) 83 72.49 (30.56) 3.91 [ -5.28, 13.10 ]
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours MIG-intens Favours MIG
A P P E N D I C E S
Appendix 1. MEDLINE search strategy
MEDLINE (via PubMed)
Thursday, August 3, 2017 (726 hits):
Search terms to locate drug abuse:
1. ”Substance-Related Disorders“[MeSH]
2. addict*[tiab] OR overdose[tiab] OR intoxicat*[tiab] OR abstin*[tiab] OR abstain*[tiab] OR withdrawal*[tiab] OR abuse*[tiab] OR
use*[tiab] OR misuse[tiab] OR disorder*[tiab] OR dependen*[tiab]
3. #1 or #2
Search terms to identify drugs:
4. ”heroin”[mh] OR heroin[tiab]
5. narcotic*[tiab]
6. drug[tiab]ORpolydrug[tiab]OR substance[tiab]ORopioid[tw]ORopiate[tw]ORhallucinogen[tiab]ORcocaine[tw]ORbenzodi-
azepine*[tw] OR amphetamine*[tw] OR “anti-anxiety-agents”[tiab] OR barbiturate*[tiab] OR “lysergic acid”[tiab] OR ketamine[tiab]
OR cannabis[tiab] ORmarihuana[tiab] OR hashish[tiab] OR opium[tiab] OR inhalant*[tiab] OR solvent[tiab] OR steroid*[tiab] OR
methadone[tiab] OR morphine[tiab] OR ecstasy[tiab] OR MDMA[tiab]
7. ”Street Drugs“[MeSH]
8. ”Designer Drugs”[MeSH]
9. #4 or #5 or #6 or #7 or #8
Search terms to identify alcohol:
10. alcohol*[tiab]
11. binge[tiab] OR drink*[tiab]
12. alcoholism[MeSH]
13. alcoholic Intoxication [MeSH]
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14. ”Drinking behavior”[MeSH]
15. #10 or #11 or #12 or #13 or #14
Search terms to locate interventions:
16. psychotherapy [MeSH]
17. incentive*[tiab] OR voucher[tiab] OR psychotherap*[tiab] OR psychosocial*[tiab] OR ”behaviour therapy” [tiab] OR ”behavior
therapy”[tiab] OR reinforcement[tiab] OR motivation*[tiab] OR contingent*[tiab] OR advice[tiab] OR biofeedback[tiab] OR com-
munity[tiab] OR stimulation[tiab] OR education*[tiab]
18. ”brief intervention”[tiab]
19. ”early intervention”[tiab]
20. ”minimal intervention” [tiab]
21. ”counselling“[MeSH] or counsel*[tiab]
22. ”cognitive therapy” [tiab]
23. ”family therapy” [tiab]
24. ”social skill”[tiab]
25. ”stress management training” [tiab]
26. ”supportive expressive therapy” [tiab]
27. neurobehavioral* [tiab]
28. ”coping skill”[tiab]
29. ”self-control training”[tiab]
30. ”social support”[MeSH]
31. ”relaxation techniques”[MeSH]
32. ”case management”[MeSH]
33. #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30 or #31 or #32
Search terms to locate randomised controlled trials
34. randomised controlled trial [pt]
35. controlled clinical trial [pt]
36. random*[tiab]
37. placebo [tiab]
38. drug therapy [sh]
39. trial [tiab]
40. groups [tiab]
41. #34 or #35 or #36 or #37 or #38 or #39 or #40
42. Animals [mh] NOT Humans [mh]
43. #41 NOT #42
44. #3 AND #9 AND ##15 AND #33 AND #43
Appendix 2. CENTRAL (CLIB) search strategy
The Cochrane Library
Issue 7, July 2017 (613 hits)
#1. MeSH descriptor Substance-Related Disorders explode all trees
#2. ((stimulant* or polydrug* or drug* or substance) near/3 (abuse* or abusing or depend* or addict* or disorder* or intoxicat* or
misus* or use* )):ti,ab
#3. (#1 OR #2)
#4. (abuse* or abusing or depend* or addict* or depend* or overdos* or withdraw* or abstain* or abstinen* or disorder* or intoxicat*
or misus*):ti,ab,kw
#5. use*:ti,ab
#6. (#4 OR #5)
#7. MeSH descriptor Narcotics explode all trees
#8. (heroin or morphine* or diamorphine or diacetylmorphine or morfin* or narcotic* or methadone):ti,ab,kw
#9. MeSH descriptor Methadone explode all trees
#10. (Opioid* or opiate* or opium):ti,ab,kw
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#11. MeSH descriptor Amphetamine explode all trees
#12. (amphetamine* or dextroamphetamine* or methamphetamine or Methylamphetamine*):ti,ab,kw
#13. MeSH descriptor Methamphetamine explode all trees
#14. (ecstasy or MDMA or hallucinogen*):ti,ab,kw
#15. MeSH descriptor Hallucinogens explode all trees
#16. MeSH descriptor Street Drugs explode all trees
#17. MeSH descriptor Cocaine explode all trees
#18. (crack or cocaine):ti,ab,kw
#19. MeSH descriptor Cannabis explode all trees
#20. (cannabis or marijuana or marihuana or Hashish):ti,ab,kw
#21. (Lysergic NEXT Acid):ti,ab,kw
#22. (LSD):ti,ab,kw
#23. (benzodiazepine* or barbiturate* or ketamine or solvent or inhalant):ti,ab,kw
#24. (#7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21
OR #22 OR #23)
#25. (#6 AND #24)
#26. (#3 OR #25)
#27. (alcohol*):ti,ab,kw
#28. (binge or drink*):ti,ab
#29. MeSH descriptor Drinking Behavior explode all trees
#30. MeSH descriptor Alcoholism explode all trees
#31. MeSH descriptor Alcoholic Intoxication explode all trees
#32. (#27 OR #28 OR #29 OR #30 OR #31)
#33. MeSH descriptor Psychotherapy explode all trees
#34. (psychotherap* or psychosocial or voucher or reinforcement or motivation* or contingent* or biofeedback or community or
stimulation or education* or counsel*):ti,ab,kw
#35. (social near/2 skill*):ti,ab
#36. (coping near/2 skill):ti,ab
#37. MeSH descriptor Counseling explode all trees
#38. (behavi* near/2 therap*):ti,ab
#39. MeSH descriptor Reinforcement (Psychology) explode all trees
#40. (brief near intervention):ti,ab
#41. (early near intervention):ti,ab
#42. (minimal near intervention):ti,ab
#43. (cognitive near therapy):ti,ab
#44. (family near therapy):ti,ab
#45. (stress near management near training):ti,ab
#46. (supportive near expressive near therapy):ti,ab
#47. MeSH descriptor Social Support explode all trees
#48. MeSH descriptor Case Management explode all trees
#49. (self near control near training):ti,ab
#50. neurobehavioral*:ab,ti
#51. (#33 OR #34 OR #35 OR #36 OR #37 OR #38 OR #39 OR #40 OR #41 OR #42 OR #43 OR #44 OR #45 OR #46 OR #
47 OR #48 OR #49 OR #50)
#52. (#26 AND #32 AND #51)
#53. ”(#26 AND #32 AND #51) in Cochrane Central Register of Controlled Trials“
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Appendix 3. Embase search strategy
Embase (via embase.com)
Thursday, August 3, 2017 (695 hits)
#1. ’addiction’/exp
#2. dependen*:ab,ti OR addict*:ab,ti OR overdos*:ab,ti OR intoxicat*:ab,ti OR abstin*:ab,ti OR abstain:ab,ti OR withdraw*:ab,ti OR
abus*:ab,ti OR use*:ab,ti OR misus*:ab,ti OR disorder*:ab,ti
#3. #1 OR #2
#4. ’diamorphine’/exp
#5. diamorphine:ab,ti OR heroin:ab,ti OR narcotic*:ab,ti OR drug*:ab,ti OR polydrug:ab,ti OR substance:ab,ti OR opioid:ab,ti OR
opiate:ab,ti OR hallucinogen:ab,ti OR cocaine:ab,ti OR benzodiazepine:ab,ti OR amphetamine:ab,ti OR ’anti-anxiety-agents’:ab,ti OR
barbiturate:ab,ti OR ’lysergic acid’:ab,ti OR ketamine:ab,ti OR cannabis:ab,ti OR marihuana:ab,ti OR marijuana:ab,ti OR hashish:
ab,ti OR opium:ab,ti OR inhalant:ab,ti OR solvent:ab,ti OR steroid:ab,ti OR methadone:ab,ti OR morphine:ab,ti OR ecstasy:ab,ti
OR mdma:ab,ti
#6. ’designer drug’/exp
#7. ’street drug’/exp
#8. #5 OR #6 OR #7
#9. alcohol*:ab,ti OR binge:ab,ti OR drink*:ab,ti
#10. ’alcohol intoxication’/exp
#11. drinking behavior’/exp
#12. ’alcohol abuse’/exp
#13. #9 OR #10 OR #11 OR #12
#14. ’psychotherapy’/exp
#15. incentive*:ab,ti OR voucher:ab,ti OR psychotherap*:ab,ti OR psychosocial*:ab,ti OR reinforcement:ab,ti OR motivation*:ab,ti
OR contingent*:ab,ti OR advice:ab,ti OR biofeedback:ab,ti OR community:ab,ti OR stimulation:ab,ti OR education*:ab,ti
#16. ’behaviour therapy’:ab,ti OR ’behavior therapy’:ab,ti
#17. counsel*:ab,ti
#18. ’counseling’/exp
#19. ’cognitive therapy’:ab,ti OR ’family therapy’:ab,ti OR ’social skill’:ab,ti OR ’stress management training’:ab,ti OR ’supportive
expressive therapy’:ab,ti
#20. ’coping skill’:ab,ti OR ’social skill’:ab,ti
#21. ’social support’/exp
#22. ’case management’/exp
#23. ’relaxation therapy’:ab,ti
#24. ’self-control training’:ab,ti
#25. neurobehavioral*:ab,ti
#26. #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23
OR #24 OR #25
#27. ’crossover procedure’/exp
#28. ’double blind procedure’/exp
#29. ’single blind procedure’/exp
#30. ’controlled clinical trial’/exp
#31. ’clinical trial’/exp
#32. placebo:ab,ti OR ’double blind’:ab,ti OR ’single blind’:ab,ti OR assign*:ab,ti OR allocat*:ab,ti OR volunteer*:ab,ti
#33. random*:ab,ti OR factorial*:ab,ti OR crossover:ab,ti OR (cross:ab,ti AND over:ab,ti)
#34. ’randomized controlled trial’/exp
#35. #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34
#36. #3 AND #8 AND #13 AND #26 AND #35 AND [humans]/lim AND [embase]/lim
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Appendix 4. CINAHL search strategy
CINAHL (via EBSCO)
Thursday, August 3, 2017 (278 hits)
S01. MH ”Substance Use Disorders“
S02. TX(drug N3 addict*) or TX(drug N3 dependen*) or TX(drug N3 abuse*) or TX(drug N3 misus*) or TX(drug N3 use*)
S03. TX(substance N3 addict*) or TX(substance N3 dependen*) or TX(substance N3 abuse*) or TX(substance N3 misus*)
S04. S1 or S2 or S3
S05. TX(addict* ORoverdos* OR intoxicat* OR abstin* OR abstain ORwithdraw*OR abus* ORmisus* ORdisorder* ORdependen*
OR use*)
S06. MH ”Heroin“
S07. MH ”Narcotics“
S08. MH ”Designer Drugs“
S09. TX(polydrug or opioid or opiate or opium or hallucinogen or cocaine or benzodiazepine* or amphetamine*or “anti-anxiety-agents”
or barbiturate* or “lysergic acid” or ketamine or cannabis or marihuana or hashish or inhalant* or solvent or steroid* or methadone or
morphine)
S10. TI ecstasy or TI mdma or AB ecstasy or AB mdma
S11. S6 or S7 or S8 or S9 or S10
S12. S5 and S11
S13. S4 or S12
S14. TI alcohol* or AB alcohol*
S15. TI drink* or TI binge or AB drink* or AB binge
S16. MH ”Alcoholism“
S17. MH ”Alcoholic Intoxication“
S18. (MH ”Drinking Behavior+“)
S19. S14 or S15 or S16 or S17 or S18
S20. MH ”Clinical Trials+“
S21. PT Clinical trial
S22. TI clinic* N1 trial* or AB clinic* N1 trial*
S23. TI ( singl* or doubl* or trebl* or tripl* ) and TI ( blind* or mask* )
S24. AB ( singl* or doubl* or trebl* or tripl* ) and AB ( blind* or mask* )
S25. TI randomi?ed control* trial* or AB randomi?ed control* trial*
S26. MH ”Random Assignment“
S27. TI random* allocat* or AB random* allocat*
S28. MH ”Placebos“
S29. TI placebo* or AB placebo*
S30. MH ”Quantitative Studies“
S31. S20 or S21 or S22 or S23 or S24 or S25 or S26 or S27 or S28 or S29 or S30
S32. S13 and S19 and S31
S33. S13 and S19 and S31
Limiters - Exclude MEDLINE records; Human
Appendix 5. PsycINFO search strategy
PsycINFO (via EBSCO)
July, Week 4, 2017 (947 hits)
1. (((psychotherap*) OR TI(psychosocial*) OR TI(”behaviour therapy“) OR TI(”behavior therapy“) OR TI(reinforcement) OR
TI(motivation*)ORTI(contingent*)ORTI(advice)ORTI(biofeedback)ORTI(community)ORTI(stimulation)ORTI(education*)
OR TI(incentive*) OR TI(voucher)) OR ((psychotherap*) OR AB(psychosocial*) OR AB(”behaviour therapy“) OR AB(”behavior
therapy“)ORAB(reinforcement)ORAB(motivation*)ORAB(contingent*)ORAB(advice)ORAB(biofeedback)ORAB(community)
OR AB(stimulation) OR AB(education*) OR MJ(”psychotherapy“) OR AB(incentive*) OR AB(voucher)))
2. ((TI(alcohol*) ORTI(binge) ORTI(drink*)) OR (AB(alcohol*)ORAB(binge) ORAB(drink*)) OR (KW(alcohol*)ORKW(binge)
OR KW(drink*)) OR DE(Alcoholism) OR DE(”Alcohol intoxication“) OR DE(”Alcohol drinking patterns“))
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3. ((KW(”heroin”) OR KW(”morphine”)) OR KW(”narcotics”) OR (TI(drug) OR AB(drug) ORTI(polydrug) OR AB(polydrug) OR
TI(substance) OR AB(substance) OR TI(opioid) OR AB(opioid) OR TI(opiate) OR AB(opiate) OR TI(”hallucinogenic drugs”) OR
AB(”hallucinogenic drugs”) OR KW(”psychedelic drugs”) OR KW(”Lysergic Acid Diethylamide”) OR TI(LSD) OR AB(LSD) OR
TI(cocaine) OR AB(cocaine) OR TI(benzodiazepine*) OR AB(benzodiazepine*) OR TI(”amphetamine”) OR AB(”amphetamine”)
OR TI(”anti-anxiety-agents”) OR AB(”anti-anxiety-agents”) OR TI(barbiturate*) OR AB(barbiturate*) OR TI(ketamine) OR
AB(ketamine) OR TI(”cannabis”) OR AB(”cannabis”) OR TI(”marihuana”) OR AB(”marihuana”) OR TI(hashish) OR AB(hashish)
OR TI(opium) OR AB(opium) OR TI(”inhalant abuse”) OR AB(”inhalant abuse”) OR TI(solvent) OR AB(solvent) OR TI(steroid*)
ORAB(steroid*)ORTI(”methadone”)ORAB(”methadone”)ORTI(ecstasy)ORAB(ecstasy)ORTI(”methylenedioxyamphetamine”)
OR AB(”methylenedioxyamphetamine”)) OR (KW(street drug*) OR KW(designer drug*)))
4. (SU(”drug abuse“) OR (KW(addict* OR abus* OR dependen*)) OR TX(overdose) OR TX(intoxicat*) OR TX(abstin*) OR
TX(abstain) OR TX(withdrawal) OR TX(abuse) OR TX(use) OR TX(misuse) OR TX(disorder*) OR KW(”drug addiction”))
5. DE(treatment effectiveness evaluation)
6. DE(clinical trials)
7. DE(mental health program evaluation)
8. DE(placebo)
9. TI(placebo*) OR AB(placebo*)
10. AB(randomly)
11. TI(randomi*ed) OR AB(randomi*ed)
12. TI(trial) OR AB(trial)
13. TI((singl* OR doubl* OR trebl* OR tripl*) W3 (blind* ORmask* OR dummy)) OR AB((singl* OR doubl* OR trebl* OR tripl*)
W3 (blind* OR mask* OR dummy))
14. TI((control*) W3 (trial* OR study OR studies OR group*)) OR AB((control*) W3 (trial* OR study OR studies OR group*))
15. TI(factorial*) OR AB(factorial*)
16. TI(allocat*) OR AB(allocat*)
17. TI(assign*) OR AB(assign*)
18. TI(volunteer*) OR AB(volunteer*)
19. 5 AND 6 AND 7 AND 8 AND 9 AND 10 AND 11 AND 12 AND 13 AND 14 AND 15 AND 16 AND 17 AND 18
20. 1 AND 2 AND 3 AND 4 AND 19
21. 20 AND (Population Group: Human)
Appendix 6. Criteria for risk of bias in RCTs and CCTs
Item Judgement Description
1. Random sequence generation (selection
bias)
Low risk The investigators describe a random component in the sequence gener-
ation process such as: random number table; computer random num-
ber generator; coin tossing; shuffling cards or envelopes; throwing dice;
drawing of lots; minimisation
High risk The investigators describe a non-random component in the sequence
generation process such as: odd or even date of birth; date (or day) of
admission; hospital or clinic record number; alternation; judgement of
the clinician; results of a laboratory test or a series of tests; availability of
the intervention
Unclear risk Insufficient information about the sequence generation process to permit
judgement of low or high risk
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2. Allocation concealment (selection bias) Low risk Investigators enrolling participants could not foresee assignment because
one of the following, or an equivalentmethod, was used to conceal alloca-
tion: central allocation (including telephone, web-based, and pharmacy-
controlled, randomisation); sequentially numbered drug containers of
identical appearance; sequentially numbered, opaque, sealed envelopes
High risk Investigators enrolling participants could possibly foresee assignments
because one of the following method was used: open random allocation
schedule (e.g. a list of random numbers); assignment envelopes without
appropriate safeguards (e.g. if envelopes were unsealed or nonopaque or
not sequentially numbered); alternation or rotation; date of birth; case
record number; any other explicitly unconcealed procedure
Unclear risk Insufficient information to permit judgement of low or high risk This
is usually the case if the method of concealment is not described or not
described in sufficient detail to allow a definite judgement
3. and 4. Blinding of outcome assessor (de-
tection bias).
Objective outcomes.
Subjective outcomes.
Low risk Noblinding of outcome assessment, but the review authors judge that the
outcome measurement is not likely to be influenced by lack of blinding
Blinding of outcome assessment ensured, and unlikely that the blinding
could have been broken
High risk No blinding of outcome assessment, and the outcome measurement is
likely to be influenced by lack of blinding
Blinding of outcome assessment, but likely that the blinding could have
been broken, and the outcome measurement is likely to be influenced by
lack of blinding
Unclear risk Insufficient information to permit judgement of low or high risk
5. Incomplete outcome data (attrition bias)
For all outcomes except retention in treat-
ment or drop-out
Low risk No missing outcome data
Reasons for missing outcome data unlikely to be related to true outcome
(for survival data, censoring unlikely to be introducing bias)
Missing outcome data balanced in numbers across intervention groups,
with similar reasons for missing data across groups
For dichotomous outcome data, the proportion of missing outcomes
comparedwith observed event risk not enough tohave a clinically relevant
impact on the intervention effect estimate
For continuous outcome data, plausible effect size (difference inmeans or
standardised difference in means) among missing outcomes not enough
to have a clinically relevant impact on observed effect size
Missing data have been imputed using appropriate methods
All randomised participants are reported/analysed in the group they were
allocated to by randomisation irrespective of non-compliance and co-
interventions (intention to treat)
High risk Reason for missing outcome data likely to be related to true outcome,
with either imbalance in numbers or reasons for missing data across
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intervention groups
For dichotomous outcome data, the proportion of missing outcomes
compared with observed event risk enough to induce clinically relevant
bias in intervention effect estimate
For continuous outcome data, plausible effect size (difference in means
or standardised difference in means) among missing outcomes enough
to induce clinically relevant bias in observed effect size
’As-treated’ analysis done with substantial departure of the intervention
received from that assigned at randomisation
Unclear risk Insufficient information to permit judgement of low or high risk (e.g.
number randomised not stated, no reasons for missing data provided;
number of drop-out not reported for each group)
WH A T ’ S N E W
Date Event Description
14 June 2018 New citation required but conclusions have not changed Clinical implications downgraded to: ”no reliable con-
clusions can be drawn regarding the effectiveness of dif-
ferent types of psychosocial interventions for the target
condition“
3 August 2017 New search has been performed We updated the searches and included three new studies,
with a total of 231 participants. The new ’Risk of bias’
assessment introduced ”Selective reporting“ as a domain.
Also, we think that lack of blinding of participants and
personnel did not introduce bias and we did not assess
the risk of performance bias
Feldman et al. 2011 was rated as having unclear risk of
bias due to the lack of information on randomisation
(selection bias)
Clinical implications downgraded to: ”no reliable con-
clusions can be drawn regarding the effectiveness of dif-
ferent types of psychosocial interventions for the target
condition“
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H I S T O R Y
Protocol first published: Issue 8, 2011
Review first published: Issue 11, 2012
Date Event Description
14 November 2014 Amended Amended typo in the PLS
14 November 2014 New citation required but conclusions have not
changed
No new studies included.
23 June 2014 New search has been performed Searches updated
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
According to the protocol we intended to exclude studies comparing psychosocial with pharmacological treatments. However, we
exempted trials with two psychosocial arms in addition to pharmacological arms from this rule in the review. We did not conduct the
subgroup/sensitivity analyses planned in the protocol owing to the lack of studies identified. We simplified the wording of the primary
and secondary outcome measures from those in the protocol for ease of presentation, as follows:
1. reduction and/or stabilisation of alcohol use = alcohol use or abstinence;
2. illicit drug use outcomes (changes in illicit drug use) = illicit drug use or abstinence.
We have added new references to the Background sections ’Description of the condition’ and ’Why is it important to do this review’, to
reflect recent developments in the field. We reduced the text in the sections ’Experimental interventions’ and ’Types of participants’ so
as to exclude examples. We removed mention of the Newcastle-Ottawa scale for assessing the quality of non-randomised studies from
the review as it was not used in any of the studies (observational studies were not included in the review).
We have assessed the risk of selective reporting bias.
We have renamed and moved the secondary outcome ”Engagement in further treatment (i.e. drop-out rates)“ among primary outcomes
as ”retention in treatment (measured as number of people completing all treatment sessions or retained at three months - for studies
of brief interventions).“
I N D E X T E R M S
Medical Subject Headings (MeSH)
Adaptation, Psychological; Alcohol Drinking [∗prevention & control; psychology]; Cocaine-Related Disorders [complications; ther-
apy]; Hepatitis C [prevention & control]; Motivational Interviewing [methods]; Psychotherapy [∗methods]; Psychotherapy, Brief;
Randomized Controlled Trials as Topic; Substance-Related Disorders [∗complications; therapy]; Temperance
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MeSH check words
Adult; Humans
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